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A major challenge faced by dairy industries is the extraction of whey proteins from milk 
without pre-treatment, because of the presence of colloidal solids and the complex 
composition of milk. Various methods have been investigated to isolate whey proteins but 
other than the extraction of lactoferrin, none have been successful because of high processing 
costs and low product yield. To overcome some of these challenges, this thesis focused on the 
specific isolation of β-lactoglobulin, in particular without involving pre-treatment of the milk. 
Previous investigations showed β-lactoglobulin to be allergenic towards some infants and 
hence its removal from whey and milk was the main objective of this thesis. Isolating this 
protein from milk using a single-step extraction process has not been demonstrated 
previously. 
A Protein A Mimetic (PAM) ligand, originally designed for isolation of Immunoglobulin G 
from a variety of sources, was shown in previous unpublished work to have an unexpected 
affinity for β-lactoglobulin. In the current work, the equilibrium/static binding capacity of 
this PAM ligand immobilized on a chromatography resin was determined using varying 
concentrations of pure β-lactoglobulin in neutral aqueous solutions. An affinity 
chromatography resin was created by amine-coupling the ligand to an activated resin (N-
hydroxysuccinimidyl-Sepharose 4 Fast Flow), and its equilibrium binding capacity was found 
to be 54.11+0.03  mg β-lactoglobulin/g wet, drained resin.   
PAM tetramer ligand showed some cross-reactivity with caseins and immunoglobulins, but 
the majority of these proteins were recovered in the regeneration step. The majority of the β-
lactoglobulin was recovered during elution, with minor traces of α-lactalbumin and 
immunoglobulins. 
A novel, cost effective and scalable method was developed to isolate β-lactoglobulin from 
milk using an immobilized tetramer peptide ligand, which had previously shown high affinity 
towards β-lactoglobulin in the presence of other milk proteins. Previous research had shown 
that the peptide ligand maintained selectivity over a range of buffer pH values, but the 
optimum selectivity was found to be at pH 7. At buffer pH 7 and a conductivity of around 8 
mS/cm, the affinity resin bound almost all β-lactoglobulin present in whey/milk, with only 
minor leakage in flowthrough fractions. An advantage to this process was the use of low salt 
during the elution process. Bound β-lactoglobulin was observed to elute at a buffer 
iv 
 
conductivity of 22 mS/cm.  
The results confirmed that β-lactoglobulin could be selectively removed from milk, thereby 
producing modified milk suitable for infant intake. In addition, β-lactoglobulin has uses in the 
confectionary and protein supplement industries and can be used as a gelling and foaming 
agent in functional foods. Suggestions for further work are expected to support development 






















As rightly said, Life is never easy and hard work is definitely required to achieve success! 
The end of my Master‘s degree has shaped me into a very different being, all through where I 
have gained a lot of knowledge. Words are never sufficient to express my gratitude to those 
who have been my guiding light. 
Conan, you are the best supervisor any student can ever be blessed with. I have learnt a lot 
throughout and words will never be able to justify the tremendous amount of encouragement 
you have always given me. You have always helped me regain my confidence and your 
guidance will always be held high. 
Simone, thank you very much for the knowledge you have bestowed upon me. You have 
been a very good friend and an inspirational guide too. 
Rayleen, no one can ever get a supportive lab manager as you. I would sincerely like to 
acknowledge you for having helped me immensely throughout my research.  
I would like to thank the department of Chemical and Process Engineering, University of 
Canterbury for partially funding my research with the ―Research and Innovation Tech 
Jumpstart prize‖. 
I wish to acknowledge CAPE technical staffs, post-graduate students and administrators for 
their support and cooperation. 
John Abrahamson, I can never thank you enough for having constantly motivated me and 
advising me throughout my thesis. Your invaluable guidance has always helped me move 
forward.  
Dr. Prasanna Ponnumallayan, thank you for guiding me throughout my thesis. Your support 
and care has always helped me stay strong. Dr. Xiao Wei Tew, thank you for staying beside 
through my happy and tough days. 
To my best friend across the sea, Ms. Nivedita Narayanan, you have remained a strong pillar 
of support. Thank you for your love and encouragement throughout this journey. My deepest 
gratitude to my extended family for their warm wishes and immense love. 
vi 
 
The thesis would not have been successful without the immense encouragement, 
unconditional love and care of my beloved parents – Mr. Balu Chandrasekaran and Mrs. 
Arthi Chandrasekaran. I can never thank you enough for staying beside me through my ups 
and downs. Thank you very much for helping me regain my confidence and being there for 
me in every step of life. My sister, role model, guide and little mother - Dr. Neha 
Chandrasekaran, thank you very much for having helped me all through my research. I could 
not have done anything in life without your unconditional love and guidance. You are the 
best sister anyone could be blessed with and I can never thank you enough for having helped 
me choose the right path. 
To my beloved Master, Gurinder Singh Dhillon, words can never justify the abundant grace 
you have showered upon me. Your unconditional love, humbleness and presence has made 
me a stronger person. Thank you very much for having helped me through this phase when 
things seemed impossible and having held my hand always. Words can never express the 















TABLE OF CONTENTS 
Abstract .................................................................................................................................... iii 
Acknowledgements .................................................................................................................... v 
List of figures ............................................................................................................................. x 
List of Tables ........................................................................................................................... xii 
Abbreviations ......................................................................................................................... xiii 
CHAPTER 1 - Introduction ................................................................................................... 1-1 
1.1 Background and Significance.................................................................................. 1-1 
1.2 Objectives ................................................................................................................ 1-4 
1.3 Thesis organization ................................................................................................. 1-4 
CHAPTER 2 - Literature review ........................................................................................... 2-1 
2.1 Introduction ............................................................................................................. 2-1 
2.2 Global milk production ........................................................................................... 2-1 
2.3 Milk constituents ..................................................................................................... 2-3 
2.3.1.1 Milk proteins – Properties and applications..................................................... 2-6 
2.4 Protein Purification in dairy industry .................................................................... 2-13 
2.4.1 Precipitation ................................................................................................... 2-14 
2.4.2 Membrane Filtration ...................................................................................... 2-15 
2.4.3 Chromatography ............................................................................................ 2-16 
2.5 Packing material .................................................................................................... 2-21 
2.5.1 Protein A Mimetic peptide ligand .................................................................. 2-21 
2.6 Kinetic models-Protein adsorption ........................................................................ 2-23 
2.6.1 Langmuir model ............................................................................................. 2-23 
2.6.2 Freundlich model ........................................................................................... 2-25 





CHAPTER 3 – Materials and Methodology .......................................................................... 3-1 
3.1 Immobilisation of tetramer peptide on a chromatography matrix........................... 3-1 
3.1.1 Preparation of solutions ................................................................................... 3-1 
3.1.2 Immobilisation process - protocol ................................................................... 3-2 
3.2 Amino Acid sequence comparison .......................................................................... 3-3 
3.3 Equilibrium/Static Binding capacity determination of resin ................................... 3-3 
3.3.1 Protein standards .............................................................................................. 3-3 
3.3.2 Nanodrop 1000 UV Spectrophotometer .......................................................... 3-4 
3.3.3 Langmuir isotherm ........................................................................................... 3-4 
3.4 Isolation of β-lac from whey/milk samples – Dynamic conditions ........................ 3-6 
3.4.1 Preparation of whey solution ........................................................................... 3-6 
3.4.2 AKTA Explorer 10 .......................................................................................... 3-6 
3.4.3 Chromatography column preparation .............................................................. 3-7 
3.4.4 Peptide affinity chromatography...................................................................... 3-8 
3.5 Freeze dryer ............................................................................................................. 3-8 
CHAPTER 4 - Results and Discussion .................................................................................. 4-1 
4.1 Peptide immobilisation on a chromatography matrix ............................................. 4-1 
4.1.1 Ratio of peptide solution (concentration-10 mg/mL): resin volume~0.5:1 
mL………………………………………………… ....................................................... 4-1 
4.1.2 Ratio of peptide solution (concentration-10 mg/mL): resin volume~1:0.5 
mL………… ................................................................................................................... 4-3 
4.2 Relation between dry and wet resin ............................................................................. 4-4 
4.3 Batch experiments ........................................................................................................ 4-5 
4.3.1 Equilibrium/ Static binding capacity of Tetramer Peptide resin ...................... 4-5 
4.3.2 Langmuir isotherm with varying salt strengths ............................................. 4-16 
4.3.3 Elution of bound β-lactoglobulin ......................................................................... 4-18 
4.4 Dynamic conditions – Separation of β-lac ................................................................. 4-20 
4.4.1 Ratio of peptide solution (10 mg/mL):resin volume~0.5: 1 mL .................... 4-21 
ix 
 
4.4.2 Ratio of peptide solution (10 mg/mL):resin volume~1:0.5 mL ..................... 4-27 
4.5 Amino acid sequence comparison – FC and β-lac ................................................. 4-29 
CHAPTER 5 - Conclusions and recommendations ............................................................... 5-1 
5.1 Conclusions ............................................................................................................. 5-1 
5.1.1 Tetramer peptide resin immobilisation ............................................................ 5-1 
5.1.2 Adsorption/Batch experiments......................................................................... 5-1 
5.1.3 Elution Experiments......................................................................................... 5-2 
5.1.4 Peptide affinity separation of β-lac from whey solution and milk................... 5-2 
5.1.5 Applications ..................................................................................................... 5-3 
5.2 Recommendations for future work .......................................................................... 5-3 
References .............................................................................................................................. R-1 
APPENDICES .................................................................................................................... A-1 
Appendix A: β-lac UV Absorbance Calibration curve ...................................................... A-1 














List of figures 
Figure 2-1 Milk produced in the World past 3 years (Agriculture and Horticulture 
Development Board, 2015) .................................................................................................... 2-2 
Figure 2-2: NZ milk production for years 2011 and 2014 (Dairy Companies Association of 
New Zealand, 2015) ............................................................................................................... 2-3 
The amino-acid sequence and 3-dimensional structure of β-lac show that it is a member of 
lipocalin family, a widely diverse family, most of which bind small hydrophobic ligands and 
thus may act as specific transporters. (Kontopidis et al., 2004). ........................................... 2-9 
Figure 2-3:Commercial milk product formulation in dairy industry (Billakanti, 2009)...... 2-14 
Figure 2-4: Membrane processes for separating desired dairy components (Brans et al., 2004)
.............................................................................................................................................. 2-16 
Figure 2- 5: Schematic representation of tetramer peptide (PAM) ...................................... 2-23 
Figure 3-1: AKTA Explorer 10 system……………………………………………………..3-7 
Figure 4-1: Chromatogram showing the absorbance of samples taken from the supernatant of 
the immobilisation solution over time, showing the immobilisation process, (P:R – 0.5:1 
mL)…………………………………………………………………………………………. 4-2 
Figure 4- 2: Chromatogram showing the absorbance of samples taken from the supernatant of 
the immobilisation solution over time, showing the immobilisation process, (P:R–1:0.5 mL)...
................................................................................................................................................ 4-4 
Figure 4-3: Relation between dry and wet resin .................................................................... 4-5 
Figure 4- 4: Scatchard plot for wet resin at 0.2, 0.5, 1.65, 4.62, 8.93 and 21.89 mg/mL β-lac, 
after 1 h binding ..................................................................................................................... 4-7 
Figure 4-5: Adsorption capacities (mg/g wet resin) at 0.7, 1.55, 3.32, 6.88, 12.46 and 26.22 
mg/mL β-lac, after 1, 2 and 3 h binding ................................................................................ 4-8 
Figure 4-6: Langmuir isotherm for β-lac adsorption to a resin prepared with peptide 
solution:resin volume~0.5:1 mL, after 1 h binding ............................................................... 4-9 
Figure 4-7: Scatchard plot for dry resin experiments (converted to wet resin basis) at 0.02, 
0.02, 0.08, 0.41, 1.1, 2.12, 3.2, 3.54, 7.77 and 12.29 mg/mL β-lac after 1 h binding ......... 4-10 
Figure 4-8: Adsorption capacities (mg/g wet resin) at 0.58, 1.22, 2.43, 4.83, 9.17, 11.7, 13.14, 
13.7, 21.04 and 25.9 mg/mL β-lac, after 1, 2, 3 and 4 h binding ......................................... 4-12 
Figure 4-9: Langmuir isotherm for β-lac adsorption to a resin prepared with peptide 
solution:resin volume~1:0.5 mL, after 1 h binding dry resin .............................................. 4-13 
xi 
 
Figure 4-10: Scatchard plot for dry resin (converted to wet resin basis) at 0.18, 1.03, 2.16, 
8.55 and 21.25 mg/mL β-lac, after 1 h binding ................................................................... 4-14 
Figure 4-11:  Adsorption capacities (mg/g dry resin) at 1.82, 3.57, 6.78, 13.02 and 26.97 
mg/mL β-lac, after 1 and 2 h binding .................................................................................. 4-15 
Figure 4-12: Langmuir isotherm for β-lac adsorption to a resin prepared with peptide 
solution:resin volume~1:0.5 mL, after 1 h binding ............................................................. 4-16 
Figure 4-13: Determination of adsorption capacities (mg/g dry resin) in presence of 20, 40, 
80, 160 and 320 mM NaCl ................................................................................................... 4-18 
Figure 4-14: Elution of bound β-lac using 0.1 M citric acid in presence of 20, 40, 80 and 160 
mM NaCl at constant pH (~6.02) ........................................................................................ 4-19 
Figure 4-15: Elution of bound β-lac using 0.1 M citric acid at varying pH (3.04 – 6.32) ... 4-20 
Figure 4-16: Chromatogram for various injection volumes of whey solution (0.25, 0.5, 4 mL 
whey solution) at 1 mL/min – pH 6.8 .................................................................................. 4-21 
Figure 4-17: SDS-PAGE gel image, showing the protein composition of feed, flowthrough 
and elution fractions from chromatogram in Figure 4-16 – for 0.5 mL whey solution ....... 4-22 
Figure 4-18 : SDS-PAGE gel image showing the protein composition of feed, flowthrough 
and elution fractions from chromatogram in Figure 4-16 for 4 mL whey solution ............. 4-23 
Figure 4-19: Chromatogram for 10 mL whey solution volume injected at 1 mL/min – pH 6.8
.............................................................................................................................................. 4-24 
Figure 4- 20: SDS-PAGE gel image, showing the protein composition of flowthrough 
fractions from chromatogram in Figure 4-19 for 10 mL whey solution .............................. 4-24 
Figure 4-21: SDS-PAGE gel image, showing the protein composition of elution fractions 
from chromatogram 4-19 for 10 mL whey solution ............................................................ 4-25 
Figure 4-22 : Chromatogram for 1 mL untreated milk as injection volume at 1 mL/min – pH 
6.9......................................................................................................................................... 4-26 
Figure 4-23: SDS-PAGE gel image showing the protein composition of feed, flowthrough 
and elution fractions from chromatogram as in Figure 4-22 for 1 mL milk ........................ 4-27 
Figure 4-24: Chromatogram showing a comparison for 1 mL and 4 mL whey solutions as 
injection volume at 1 mL/min – pH 6.8 ............................................................................... 4-28 
Figure 4-25: SDS-PAGE gel image showing the feed, flowthrough and elution fractions of 
chromatogram in Figure 4-24 for 4 mL whey solution........................................................ 4-29 
Figure 4-1: Amino acid sequences of bovine β-lac sequence and the FC region of IgG, 
showing a matching set of amino acids RTPEV (red), PTPE and PAPE (yellow) and PAVF 
and PSVF (blue) in each………………………………………………………………..….4-30 
xii 
 
List of Tables 
Table 2-1: Comparison of milk nutrients from different species (Bramaud et al., 1997) ...... 2-4 
Table 2-2: Bovine milk protein properties (Jackson et al., 2004, Gurgel et al., 2001) .......... 2-5 
Table 4-1: Area of the individual peaks (mAU•mL) at 280 and 215 nm wavelengths 
comparing immobilisation occurring over varying time intervals (Start, 1 and 3 h) to depict 
the uptake of β-lac by the tetramer peptide resin…………………………………………... 4-3 
Table 4-2: Comparison of varying Linearization plots determining the best fit for wet resin 
obtained after 1 h biniding ..................................................................................................... 4-7 
Table 4-3: Comparison of Linearization plots determining the best fit for dry resin (converted 
to wet resin quantities), after 1 h binding ............................................................................ 4-10 
Table 4-4: Equilibrium binding capacities at varying β-lac concentrations, after 1 h binding
.................................................................................................................................. ………4-11 
Table 4-5: Comparison of Linearization plots determining the best fit for dry resin (converted 








BSA Bovine Serum Albumin 
BCCA Branched-chain amino acids 
CFM Cross flow microfiltration 
DEAE Diethylaminoethyl 
DMF Dynamic membrane filtration 
EUF Electro ultrafiltration 
ELISA Enzyme-Linked Immunosorbent Assays 
EBA Expanded bed adsorption 
FAO Food and Agriculture Organization 
Fc Fragment crystallizable 
Ig Immunoglobulin 
IPA Isopropanol 
pI Isoelectric point 
LF Lactoferrin 
LP Lactoperoxidase 
MW Molecular weight 
NF Nanofiltration 
NHS N-hydroxy succinimide 
PAM Protein A Mimetic 
RO Reverse osmosis 






CHAPTER 1 - INTRODUCTION 
1.1 BACKGROUND AND SIGNIFICANCE 
Milk, more commonly known as nature‘s most complete food, has been used as an excellent 
food source for many centuries (Park, 2009). Amongst the different sources available, milk 
from domestic animals such as cows and goats has been preferred, depending on their 
availability (Agostoni et al., 2000). Milk also serves as a raw material for a diverse family of 
food products. The primary function is to meet the complete nutritional requirements, mainly 
of neonates. It is the most adaptable and flexible of all food materials, simplifying its use in 
producing various products (Fox et al., 2015).  
Bovine milk has been the major source of dairy products in developed countries, especially in 
the Western World (Park, 2009). Although bovine milk is consumed worldwide, there is a 
clear difference between this and human milk with respect to their bioactive component 
profiles, especially protein content. A comparison of protein content present in bovine and 
human milk is shown in Table 1-1. The most critical difference between these, in the context 
of this thesis, is the absence of β-lactoglobulin (β-lac) in human milk, whereas bovine milk 
contains nearly 3 g/L of β-lac. Bovine milk also has a total protein content that is three times 











Table 1-1: Comparison of protein composition in human and bovine milk (Lönnerdal et al., 
1976) 
 
 Human milk (g/L) Bovine milk (g/L) 
Casein 2.5 27.3 
Lactoferrin 1.7 Trace 
Lysozyme 0.5 Trace 
Serum albumin 0.5 0.4 
Immunoglobulin A 1.0 0.03 
Immunoglobulin G 0.03 0.6 
Immunoglobulin M 0.02 0.03 
α-lactalbumin 2.6 1.1 
β-lactoglobulin --- 3.6 
 
Human and bovine milk are considered to be the most important source of natural bioactive 
components comprising lipids, carbohydrates, peptides and specific proteins (Agostoni et al., 
2000). Initially, it was believed that milk contained only one type of protein but many years 
ago it was shown that proteins in milk could be fractionated into two well-defined groups 
comprising caseins and whey proteins. 
Identification of major caseins and whey proteins has been based on their primary structures. 
Casein is the best characterized milk protein and constitutes over 70%-80% of total bovine 
milk protein. Whey represents a source of protein ingredients for many novel food products. 
Whey proteins are well known for their high nutritional value as well as for their functional 
properties such as emulsification, stabilization, gelation and foaming in food products. These 
proteins also improve the texture of various food products including dairy products and 
confectionaries (Patel et al., 1990).Normal bovine milk contains about 3.5% protein by 
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weight, of which casein constitutes about 80% and whey proteins constitute 20% (Korhonen 
and Pihlanto-Leppälä, 2004).  
Casein, the principal protein present in bovine milk can be further classified into -casein, β-
casein and κ-casein (Thompson et al., 1965), while the major constituents of bovine whey 
include immunoglobulins (Igs), β-lac, -lactalbumin (-lac) and bovine serum albumin 
(BSA). Bovine whey proteins are comprised of approximately 50–60% β-lac (Table 1-1). β-
lactoglobulin has been demonstrated to be an allergic protein for infants and this limits the 
use of cow‘s milk for manufacturing infant formulae (Businco et al., 1993). 
To take greater advantage of the nutritional and functional properties, many processes to 
recover and concentrate whey proteins have been investigated, including demineralization 
and crystallization. One of the oldest methods for isolating whey proteins involves acid 
precipitation and denaturation. Using these methods, proteins retain their nutritive value but 
because they are insoluble in water, the proteins lack other functional properties such as 
texturizing characteristics and binding properties (Marshall, 2004). 
Other methods proposed for fractionation of whey proteins from acid whey include 
membrane filtration (Zydney, 1998), chromatography (Fee, 2010) and selective precipitation 
(Casal et al., 2006b, Lozano et al., 2008). These methods have proven good for laboratory 
purification purpose but have not been widely used for industrial-scale purpose because of 
their complexity, high processing cost, poor selectivity and product degradation during 
extreme heat treatment and excess salt usage.  
The complex nature of milk has proven to be disadvantageous for extraction of proteins and 
has remained a challenge for several years. For instance, the presence of fat globules and 
casein micelles prevent flow through the interparticle void spaces of a packed bed 
chromatography column, thereby causing an increase in back pressure, leading to low or zero 
flow rates (Fee and Chand, 2006).  More recently, new and improved technologies are 
increasing the potential to extract milk proteins directly from whole milk. 
Previously, Igs have been recovered from complex fluids and the more commonly used 
technique for recovery of Immunoglobulin G (IgG) includes either Protein A or Protein G 
affinity chromatography (Linhult et al., 2005, Kochan et al., 1996). Less costly and more 
robust oligpeptide-based ligands with similar affinity towards Igs (Protein A mimetics or 
PAMs) were developed, mainly to avoid the use of the original bacteria-derived Protein 
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A/Protein G ligands. These PAM ligands were proven to show affinity towards IgG, but 
unexpectedly showed (in unpublished research by a PhD student in the Biomolecular 
Engineering Research Group at the University of Canterbury) affinity towards β-lac as well. 
This hence offers a new opportunity to isolate β-lac from milk (Billakanti, 2009).    
To purify milk for use in infant formulae, it is necessary to make sure that β-lac is either 
totally or partially removed from milk products intended for infant intake. There have been a 
number of techniques used in the past to isolate this protein from whey solutions, as will be 
described in Chapter 2, but the use of the PAM ligand to achieve this separation has not been 
attempted previously.  
1.2 OBJECTIVES 
The objectives of this research were as follows: 
 Investigate and characterize the PAM peptide as an affinity ligand for selective 
isolation of β-lac from whey and milk 
 To determine the equilibrium binding capacity of tetramer peptide resin to β-lac 
 To calculate the recovery of bound protein by performing elution experiments  
1.3 THESIS ORGANIZATION 
The remainder of this thesis is organized as follows: 
Chapter 2: This chapter outlines the background of the research and reviews the existing 
literature related to this study. In the first section, a brief description of milk components, 
including proteins and their uses in the dairy industry is provided. This section mainly 
focuses on the various available β-lac extraction technologies. In the second section, an 
elaborate description of our protein of interest is discussed, including its potential allergenic 
effects on infants. The final section of this chapter describes various relevant protein 
extraction techniques. This chapter also present potential applications of PAM peptide-based 
affinity ligands in the isolation of β-lac from milk. 
Chapter 3: In this chapter, a description of the equipment used is provided, along with the 
preparation of buffers and details of experimental protocols are also described. 
Chapter 4: This chapter presents the results of experimental work, including the equilibrium 
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binding capacity of the PAM resin with regard to pure β-lac. Also presented are the results of 
using the synthetic peptide ligand to isolate β-lac from milk and whey. The advantages and 
disadvantages of other methods for isolating this protein are compared with those of the 
PAM-based affinity chromatography method proposed in this research.  





































CHAPTER 2 - LITERATURE REVIEW 
2.1 INTRODUCTION   
Previously, experiments have been performed to isolate various proteins from milk for 
applications in food industries (Manji and Kakuda, 1986, Goodall et al., 2008). Because milk 
is complex, it has been difficult to extract and quantify milk proteins (Pampel et al., 2007). 
Various techniques commonly used to fractionate proteins include membrane filtration, 
adsorption, chromatography and precipitation. Direct chromatographic capture of proteins 
from milk has been of great interest and has been used in the recovery of pharmaceutical 
proteins from transgenic animals. The purification processes are mainly affected by the 
presence of solids and fat globules in milk, causing clogging of chromatographic column   
(Shah, 2000). Hence, purification methods have mainly been carried out on defatted 
milk/whey streams to prevent clogging of membranes and columns. The current processes for 
protein recovery from milk streams precede chromatographic purification methods with a 
number of steps designed to remove major milk components, including caseins and lipids 
(Shah, 2000, Swaisgood, 2003). These pre-treatment steps are deemed necessary to safeguard 
chromatographic column integrity and performance but overall suffer from serious product 
loss. Hence, to overcome these losses and obtain a high initial product recovery, direct 
capture of proteins of interest, without pre-treatment would be ideal. 
The following section (Section 2.2) includes a brief presentation of the global milk 
production practices as a background to the objectives of this research.  
2.2 GLOBAL MILK PRODUCTION 
According to recent reports released by the FAO (Food and Agriculture Organization, US) in 
2014, the total amount of milk production around the world in 2013 was approximately 636 
million tonnes. The USA was the largest cow‘s milk producer in the world in 2013, 
accounting for 14.4% of world production. Nearly 56.1% of the production was from ten 
countries, ranking USA as the highest and NZ as the eighth largest producer of cow‘s milk in 
the world (Figure 2-1). Approximately 150 million households around the globe are engaged 






Figure 2-1 Milk produced in the World past 3 years (Agriculture and Horticulture 
Development Board, 2015) 
 
With annual exports in excess of NZ $13.7 billion, the dairy industry is New Zealand‘s 
biggest export earner, accounting for more than 29% by value of the country‘s merchandise 
exports. Around 95% of the milk New Zealand produces is exported.  
Dairy productivity has risen markedly over the past decade. Milk solids (kg) include the total 
of milk proteins and fat. A gradual increase in production of milk solids has been observed 
over the past few years (Figure 2-2). Major exporting destinations for New Zealand dairy 
commodities include USA, Australia, China, Europe, Malaysia and Japan (Dairy Companies 






































Figure 2-2: NZ milk production for years 2011 and 2014 (Dairy Companies Association of 
New Zealand, 2015) 
 
According to recent reports (Figure 2-2), a gradual increase in NZ milk production has been 
observed for the period 2011-2014. 
2.3 MILK CONSTITUENTS 
The composition of bovine milk is of greatest importance in the dairy industry (Smithers, 
2008). Milk of different ruminant species, directly or as dairy products comprise food of 
outstanding importance for humans (Rose et al., 1970). With some exceptions, milk contains 
all nutrients required for the growth and development of neonates and is known as the 
primary source of nutrition for infants. Although studies have been carried out on milk 
obtained from several species such as cow, goat, and sheep, cow‘s milk has proven to serve 
benefits to human health because of its resemblance to human milk (Madureira et al., 2007, 
Andersson and Mattiasson, 2006). Table 2-1 gives a comparison of nutrients present in milk 




























Table 2-1: Comparison of milk nutrients from different species (Bramaud et al., 1997) 
 
Nutrients Human (g/L) Cow (g/L) Buffalo (g/L) Goat (g/L) 
Total solids 129 125 171 130 
Proteins 10 34 38 29 
Caseins 4 28 32 23 
Whey proteins 5.5 6 6 6 
Fat 38 31 75 45 
Lactose 71 48 49 45 
Oligosaccharides 3.8 0.03-0.06 --- 41 
Riboflavin 0.00043 0.0018 0.0010 0.0044 
Ash 2 7 8 8 
Calcium 0.34 1014 1.85 1.3 
Phosphorus 0.14 0.93 1.25 1.06 
 
Bovine milk is a rich source of bioactive compounds that are increasingly being used as 
nutraceuticals. It is a complex heterogeneous fluid consisting of essential nutrients such as 
proteins, fat globules, minerals and other minor components (Gurgel et al., 2001). Overall, 
milk comprises approximately 87% water and 13% milk solids. These milk solids are 
comprised of 8.9% non-fat solids, 3.7% triglycerides, esters and amino acids. The non-fat 
solids are further classified into a mixture of proteins (3.4% whey proteins and caseins), 
lactose (4.8%) and other minor components (0.7%) (Jackson et al., 2004). An extensive study 
has been carried out with regard to milk proteins in terms of their structure and functional 





























α-s1-casein 12-15 30.6 199 23.6 4.9-5.3 
α-s2-casein 3-4 8 209 25.3 4.9-5.3 
β-casein 9-11 30.8 209 24 5.2 
κ-casein 2-4 10.1 169 19 5.8 
WHEY PROTEINS 
α-lac 0.6-1.7 3.7 123 14 4.4 
β-lac 2-4 9.8 162 18.3 5.4 
BSA 0.4 1.2 582 67 5.1 
Lactoferrin (LF) 0.02-0.1 0.3 690 77 7.9 
Lactoperoxidase 
(LP) 
0.03 0.1 612 78 9.6 
Igs 
IgG1 0.3-0.6 1.2 --- 161 5.5-6.8 
IgG2 0.05 0.15 --- 150 7.5-8.3 
IgM 0.09 0.3 --- 1000 5.5-7.4 
IgA 0.01 0.03 --- 385-417 4.5-6.8 
 
Milk is recognized as a complete food for newborn mammals which contains a number of 
bioactive components including oligosaccharides, vitamins, minerals, proteins and lipids. 
Research has proved that milk contains high levels of Igs and other physiologically active 
compounds for warding off infection in the newborn (Séverin and Wenshui, 2005). Amongst 
all milk nutrients, proteins have a major impact on human health (Shah, 2000). These 
proteins are broadly classified into caseins and whey proteins. All proteins have shown 
differences in their physical and functional properties (Wong, 2012). 
As seen from Table 2-1 and 2-2, a clear difference in β-lac content of human and bovine milk 
is observed. Human milk contains all proteins necessary for infant nutrition and hence has 
been used for their intake, but the presence of β-lac in bovine milk may limit its use for 
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infants. Hence a process that would make bovine milk similar to human milk (devoid of β-
lac) may be very beneficial for manufacturing infant formulae. 
2.3.1.1 Milk proteins – Properties and applications 
Milk proteins contain a plethora of components, all of which contribute to the nutritional 
value of milk and are the best characterized amongst all the food proteins (Swaisgood, 2003).  
Whey has been produced as a by-product of cheese manufacturing for decades and has been 
considered as a waste product. Whey disposal has remained a big issue that poses 
environmental problems in many countries. To recover value, initially, milk proteins were 
recovered from whey streams by various precipitation methods and selective isolation 
methods (Smithers, 2008, Hidalgo and Hansen, 1971). In the recent past, research has mainly 
focussed on isolation of whey proteins from milk because these proteins have numerous 
applications in food and healthcare industries. Achievements have been reported for 
extraction of major whey proteins such as α-lac, β-lac from acid whey solutions (Smithers, 
2008). A detailed description of the different milk proteins is described in the sections below. 
2.3.1.1 Caseins 
Caseins are the best characterized milk proteins, constituting nearly 70%-80% of total bovine 
milk proteins. These proteins are known to be a good source of essential elements (such as 
calcium, amino acids and inorganic phosphates) and hence provide nutrition to neonates 
(Rose et al., 1970). All caseins are essentially found in micelles which can be then isolated by 
centrifugation or by size-exclusion chromatography. Another common method to fractionate 
caseins is by precipitation at pH 4.6, because acidification causes the casein micelles to 
aggregate by reducing the electric charge to its isoelectric point (Zhang, 2002).  
Caseins are broadly classified into: α-, β-, κ- and γ- caseins. α-casein is the most dominant 
casein in milk and is known to be calcium sensitive. In bovine milk, 65% of the casein 
fraction is comprised of the α-S1 and α-S2 subunits of molecular weights 23.6 and 25.2 kDa, 
respectively (Bhattacharyya and Das, 1999). α-S1 casein has been identified with five genetic 
variants (A, B, C, D and E) and the structure is known to consist of hydrophobic domains. On 
the other hand, α-S2 casein has been identified with two genetic variants (A and D) and is 
more hydrophilic when compared with α-S1 casein. β-casein is also known to be calcium-
sensitive, whereas κ-casein is known to be resistant to calcium precipitation. This protein 
plays a vital role in stabilization of caseins in presence of calcium (Farrell Jr et al., 2004).    
2-7 
 
2.3.1.2 Whey proteins 
Whey proteins are known to be rich in sulphur-containing amino acids such as cysteine and 
methionine and are highly soluble in aqueous buffers. Whey proteins include macropeptides, 
major proteins such as β-lac, α-lac, BSA, Igs and minor proteins such as membrane proteins, 
LP (Lactoperoxidase) and LF (Lactoferrin). The main antibody constituent of bovine milk is 
IgG, but it also contains low levels of IgM and IgA. These proteins can be denatured by 
heating them to temperatures above 65-70°C. 
 Whey proteins are typically known as globular proteins. In comparison with caseins, these 
proteins are more sensitive to heat treatment but are highly stable to pH variations (Korhonen 
and Pihlanto-Leppälä, 2004). Whey proteins possess a number of applications to human 
health and have been observed as a rich source of amino acids (Madureira et al., 2007). 
Recently, researchers have become interested in producing individual whey proteins during 
whey protein fractionation, with well-characterized functional and biological properties 
through processes that will not denature  the proteins but retain their nutritional and other 
properties (Bhattacharyya and Das, 1999). 
α-lactalbumin 
α-lactalbumin is the most abundant whey protein in human milk whey and the second most 
abundant protein in bovine milk whey. This protein comprises approximately 3.4% of total 
milk protein and 20% of total whey protein and is nearly 14.2 kDa in weight and has a 
theoretical pI of 4.82. α-lac concentration in bovine whey protein ranges between 1.2-1.5 
mg/mL (Andersson and Mattiasson, 2006). On the other hand, α-lac is the predominant whey 
protein in human milk and has a concentration of 2.44+0.64 mg/mL, after 30 days of 
lactation (Jackson et al., 2004).  
α-lac is the preferred source for infant formula because of its high tryptophan and cysteine 
content, high digestibility and low potential for causing infant allergies (Gurgel et al., 2001). 
It also possesses therapeutic uses and is therefore used in nutraceutical industries (Konrad 
and Kleinschmidt, 2008). Commercial availability of bovine α-lac allows the production of 
infant formulae that contain amino acid compositions very similar to that of human milk. 
Human and bovine α-lac shares a 72% amino acid sequence homology. Currently available 
studies suggest that α-lac digestibility is as high as that of casein and better than β-lac (Heine 
et al., 1996).  
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A number of techniques have been developed for the rapid separation of α-lac from other 
milk proteins. The optimum conditions for selective precipitation of α-lac from bovine whey 
was investigated previously by Bramaud et al. (1997). Using anion exchange 
chromatography, Manji and Kakuda (1986) described the rapid separation of both α-lac and 
β-lac whey proteins. Reviews and articles have been discussed regarding the structure, 
biological activities (Madureira et al., 2007) and nutritional aspects of α-lac (Indyk et al., 
2007, Shah, 2000). 
Although previous research has described the use of ion exchange chromatography to isolate 
α-lac from bovine whey, this process is not highly biospecific and traces of β-lac are expected 
to elute with α-lac, because both the proteins possess a similar pI. Hence, developing a ligand 
that behaves selectively towards β-lac would definitely be beneficial because we could use 
this to isolate β-lac alone, by affinity in comparison with the remaining milk proteins. This 
study has therefore been carried out to investigate the use of the PAM peptide as an affinity 
ligand to selectively isolate β-lac from whey and milk. 
β-lactoglobulin 
β-lactoglobulin, our protein of interest, is known to be the most abundant whey protein in 
ruminant‘s milk, comprising nearly 70-80% of whey proteins (Yousefi et al., 2013). It is the 
only protein without any counterpart in human milk (Sélo et al., 1999). It represents nearly 
58% of whey protein or 10% of the total protein in milk (Lozano et al., 2008). In whey, the 
concentration of β-lac is in the range of 2-4 mg/mL (Andersson and Mattiasson, 2006). Six 
genetic variants of β-lac have been identified so far; amongst these variants A and B are the 
most common. Because variant A has an additional negative charge in terms of the amino 
acid composition, it possesses a slightly lower pI value (~5.1) compared with variant B 
(~5.2), although the MW of both variants are the same (Yamamoto and Ishihara, 1999). This 
protein has a tendency to react with several caseins and α-lac to form a complex by 
hydrophobic interactions (Wang et al., 1997).  
The complex formed (β-lac and κ-casein) will lead to clogging of the chromatography 
column, thereby causing problems in the protein separation process. Hence, as mentioned 
previously, research has been carried out involving pre-treatment of milk, leading to removal 
of fat globules. This simplifies separation of milk proteins and has been the most convenient 
mode of separation. The issue with these separation modes is the involvement of pre-
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treatment which is not regarded safe for infant intake. 
The primary structure of β-lac contains 162 amino acid residues, with a total MW of 18.4 
kDa and binds well to a number of ligands (mainly hydrophobic ligands) (Wu et al., 1999). 
The secondary structure comprises of nine strands of β structure, a short helix segment and 
three helical turns. The quaternary structure depends on the medium pH and it occurs mainly 
as a stable dimer (pH between 5.2-7.5), with a MW of 36.7 kDa (Teixeira et al., 2014). Except in 
the small pH range around its pI, β-lac is present in the form of dimers at equilibrium. At 
physiological conditions (pH between 5.2 and 7.5), β-lac forms a dimer and at pH values 
between 3.5 and 5.2, it exists as an octamer with a MW of 140 kDa (Taulier and Chalikian, 
2001, De Wit and Fox, 1989).  
The amino-acid sequence and 3-dimensional structure of β-lac show that it is a member of 
lipocalin family, a widely diverse family, most of which bind small hydrophobic ligands and 
thus may act as specific transporters (Kontopidis et al., 2004).  
β-lactoglobulin possesses several positive functional attributes but some adverse behavior 
associated with allergenicity, which are explored in the following section.  
Advantages and disadvantages of β-lactoglobulin  
Hambling et al. (1992) and Liberatori (1976) reviewed the physico-chemical properties of β-
lac and its functional applications in food, healthcare and cosmetic industries. β-lac serves as 
an excellent gelling and foaming agent (Giarrocco et al., 1997). It can also be used in the 
manufacture of confectionaries (Zayas, 1997). β-lactoglobulin is the ingredient of choice in 
the formulation of modern food and beverages. It has a high concentration of essential and 
branched – chain amino acids (BCCAs). Amongst the BCCAs, leucine is known to 
significantly help in tissue growth and repair due to its solubility in water, Apart from these 
applications, β-lac also possesses biological applications (Madureira et al., 2007). 
On contrary, β-lac has proved to behave as an allergic protein for infants (Businco et al., 
1993). The protein was diagnosed to be a major allergen in 1.9 - 2.8% of the general 
population of infants in Europe. Allergenicity of β-lac has already been shown to be 
associated with the four peptides derived from cyanogen bromide cleavage of β-lac (Sélo et 
al., 1999). Hence, the use of this protein for manufacturing infant formulae is limited. 
However, there are many commercially available infant products that contain large amounts 
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of β-lac, such as Jarrow 12 formulae (Kunz et al., 2000). It is mainly because of the difficulty 
in developing an economical process for total removal of β-lac from milk that no process has 
yet been developed for its isolation. 
If a new process could be developed for selective removal of this protein from milk, it could 
have high potential for preparation of pure infant formulae (Billakanti and Fee, 2009). As a 
result of this process, the purified milk produced would be devoid of β-lac and the protein 
isolated could be used as an additive in food products. β-lactoglobulin is expected to elute 
with low salt strength (nearly 100 mM NaCl) which is compatible with its use in food 
products; although probably with minor traces of α-lac present. The milk produced would 
retain all other nutrients intact. On commercialisation, the resultant product (purified milk), 
will be preferred by those responsible for the care of infants who are allergic to standard 
milk. 
Bovine Serum Albumin 
Bovine Serum Albumin, a globular protein, exists in whey at a concentration between 0.3 and 
0.6 mg/mL and has a MW of approximately 69 kDa. The pI of this protein ranges between 
4.7and 4.9, slightly lower than β-lac and it contains 582 amino acid residues. It comprises 
nearly 8% of whey proteins in milk (Andersson and Mattiasson, 2006). This protein is 
reported to exist as a single phenotype with no variants but it does dimerise, mainly through a 
single unpaired cysteine residue in the primary structure. 
The protein is used in food industries because it possesses good gelling properties 
(Matsudomi et al., 1991) and it is also used widely in therapeutic industries (Zydney, 1998). 
BSA has also been used widely in biochemical applications (as a blocking agent) including 
immunoblots and ELISA (Enzyme-Linked Immunosorbent Assays) to prevent non-specific 
binding of antigens and antibodies. It is known to bind strongly free fatty acids because of its 
hydrophobic nature. This protein has been extracted along with α-lac and β-lac because the 
pIs of these proteins are similar to that of BSA (Billakanti, 2009). 
Immunoglobulins 
 Immunoglobulins are gamma globulin proteins that are found in all lactating species. In 
humans, Igs are classified into five classes: IgA, IgD, IgE, IgG and IgM. Amongst these, IgG 
is the most abundant immunoglobulin, and it comprises to 75% of total Igs. Each Ig possesses 
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a characteristic type of heavy chain and the physicochemical properties of the Igs also vary 
between different classes..  The MW of Igs lie between 144 and 960 kDa with their pI‘s lying 
between 5 and 7.2 (Billakanti and Fee, 2009).  
Immunoglobulins act as the first defence system against infections and diseases. Enriched 
bovine colostrum, produced from hyper immunized cows is a very good source of Igs and has 
been used as a raw material to provide passive immunity (Tomasi Jr, 1972). The 
concentrations of Igs found in bovine and human serum and mammary secretions are listed in 
Table 2-3. 
 
Table 2-3: Immunoglobulin concentrations in bovine and human serum and mammary 











Total IgG 25 32-212 0.72 
IgG1 14 20-200 0.6 
IgG2 11 12 0.12 
IgA 0.4 3.5 0.13 
IgM 3.1 8.7 0.04 
 
Human 
Total IgG 12.1 0.4 0.04 
IgA 2.5 17.4 1 
IgM 0.9 1.6 0.10 
  
Previously, IgG purification has been achieved using PAM peptide ligand because of its 
selectivity to the FC portion of IgG  (Fassina et al., 1996). 
Viral and microbial infections can be reduced and improved immune activity can be provided 
to consumers by adding Igs to infant formulae and other food products (Gapper et al., 2007). 
Lactoperoxidase 
Lactoperoxidase  is one of the valuable enzymes found in bovine milk and weighs nearly 78 
kDa with 612 amino acids, pI is approximately found to be 9.6 (Arnold, 1881). Bovine milk 
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contains 20 times higher amount of LP than that present in human milk (Gothefors and 
Marklund, 1975). The concentration of LP in bovine milk is about 30 mg/L constituting about 
1% of the whey proteins. The secondary structure of LP consists of 65% β strand and 23% α 
helix (Fox and Kelly, 2006).  
LP catalyzes the oxidation of thiocyanate by hydrogen peroxide and generates intermediate 
products with antibacterial properties which inhibit the growth of wide range of fungi and 
bacteria (Seifu et al., 2005, Korhonen and Pihlanto-Leppälä, 2004). One of the major 
advantages of LP is that it has been previously used to preserve raw milk during 
transportation from the farm to the dairy plant, where the use of a mechanical fridge is not 
feasible (Seifu et al., 2005).  
Lactoferrin 
This protein is an iron-binding glycoprotein of the transferrin family and is expressed in most 
biological fluids. It is a major component of the mammalian innate immune system 
(González-Chávez et al., 2009). Bovine LF and human LF have approximately 69% similarly 
in amino acid residues. The concentration of LF in bovine milk and whey is relatively low 
and varies throughout the milking season, generally falling within the range 20-400 mg/L 
(Palmano and Elgar, 2002). LF weighs nearly 80 kDa and has a pI of 8.6 (González-Chávez 
et al., 2009). It is one of the major whey proteins in human milk with concentrations of 1.4–
2.0 mg/mL but only a minor component in bovine milk with only one tenth (0.1–0.2 mg/mL) 
of concentration found in human milk (Elagamy et al., 1996, Playne et al., 2003).   
Isolation of LF has been achieved in both laboratory and lab-scale applications using cation 
exchange, size exclusion, affinity and hydrophobic chromatography methods (Chand, 2006, 
Indyk and Filonzi, 2005, Okonogi et al., 1988). In comparison to other milk proteins, LF has 
a much higher pI but has been easily isolated from milk using cation exchange 
chromatography (Billakanti, 2009). 
Lactoferrin has been used commercially as a natural bioactive ingredient in supplement foods 
(e.g., infant formulae and dietary supplements) and oral healthcare products (Yamauchi et al., 
2006) Because of its distinctive properties, LF has emerged as an important antimicrobial 
milk protein and recent studies show that this protein possesses applications in human health, 
by preventing growth of pathogens (González-Chávez et al., 2009, Ward et al., 2002). A 
highly purified form of LF also finds applications in cosmetics, functional food, beverages 
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and animal feed (Horton, 1995, Tomita et al., 2002).  
Before understanding the separation techniques, it is vital to gain some knowledge regarding 
the various constituents present in milk. 
2.4 PROTEIN PURIFICATION IN DAIRY INDUSTRY 
One of the important requirements for advancements made in biotechnology has been the 
development of various techniques for protein purification. Protein purification is a series of 
processes that are intended to separate them from one another within a mixture of nutrients.  
Generally, protein purification is performed based on protein native properties such as 
hydrophobicity and size (Matthews, 1984). In certain cases proteins are isolated by affinity 
ligands (Huse et al., 2002). A few multi-step processes have been developed but typically 
increase the production cost (Fee and Chand, 2006). Hence, there is a need to develop a 
chromatographic process which minimizes loss whilst maximizing the product yield. A wide 
range of techniques are available for protein separation based on end user applications and 
commercial viability. The most common methods used include salting out and adsorption 
chromatography (Etzel et al., 2000, Scopes, 2013). Although these methods have been 
investigated for decades, methods available for industrial-scale extraction of proteins are 
limited. These industrial-scale extraction methods include precipitation, chromatography, 
adsorption and membrane filtration. Depending on the end user applications, these processes 
were used to isolate the protein of interest from complex mixtures (Bhushan and Etzel, 2009, 
AbdEl-Salam, 2006, Hjorth, 1997, Etzel et al., 2000). For example: centrifugation is one of 
the commonly used methods to isolate milk fat components, thereby isolating major caseins 
and whey proteins (Korhonen and Pihlanto-Leppälä, 2004). Expanded bed adsorption has 
proved to be a potential alternative method for industrial-scale processing of complex protein 
mixtures (Noel, 2007). On the other hand, membrane filtration techniques are attractive in the 


























Figure 2-3:Commercial milk product formulation in dairy industry (Billakanti, 2009) 
 
The above-mentioned (Figure 2-4) methods possess benefits and limitations. Some of the 
milk-derived components were found to be susceptible to harsh treatments, usually employed 
in isolation processes. Additionally, is has been observed that multiple step processes 
increase the final product cost but decrease the product yield and activities (Chand, 2006). 
Because of an increasing demand and applications of dairy proteins in healthcare, food and 
pharmaceutical industries, cost effective processes need to be developed for bulk productions.  
2.4.1 Precipitation 
Precipitation is a widely used technique for recovery of proteins and other biological 
products. The selective precipitation technique involves adjusting the physical properties of 
components in solutions by addition of solvents, salts and/or heating to promote aggregation. 
Salting out is one of the most commonly used protein precipitation methods. This method has 
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been commonly used for extraction of whey proteins from whey, in laboratory scale 
(Billakanti and Fee, 2009). Using selective precipitation method, aggregation of caseins was 
observed. This was achieved by adjusting the pH of milk to around 4.6 at 40°C. In addition to 
this, selective precipitation methods have also been used to separate whey proteins from 
whey solutions.  
Previously, a variety of techniques have been carried out to isolate whey proteins from whey 
solutions. Bramaud et al. (1997) used selective precipitation for the isolation of α-lac from 
whey under heat treatment. A study was carried out using citric acid and observing the effect 
it had on the precipitation of whey proteins. Using phosphate precipitation and chitosan 
causing precipitation, Casal et al. (2006a) and Al-Mashikhi (1987) isolated β-lac from cheese 
whey. Several other precipitation methods had been developed to concentrate and isolate 
whey proteins from whey streams (Stanley et al., 1950, Richter et al., 1974). However, 
precipitation methods are not suitable for all dairy proteins and bioactive components because 
of their limitations in food and health care applications. Another limitation is their high cost 
when applied to industrial scale basis and waste disposal problems (Billakanti and Fee, 
2009).  
2.4.2 Membrane Filtration 
Membrane filtration is commonly used to concentrate milk-derived components in the dairy 
industry. Separation of fat globules in cream manufacturing, reduction of bacteria and spores 
in skim milk and concentration of casein micelles as a pre-treatment in cheese manufacturing 
were achieved using membrane processes (Brans et al., 2004, Brisson et al., 2007). As in 
Figure 2-5, membrane processes operate over a range of particle sizes from 1 nm to 10 μm. A 
number of membrane process technologies find application in the dairy industry including 
cross-flow microfiltration (CFM), ultrafiltration (UF), reverse osmosis (RO), dynamic 
membrane filtration (DMF), electro ultrafiltration (EU), and nano-filtration (NF). Recent 
developments in membrane filtration have provided exciting new opportunities for large-
scale protein and lactose fractionation including the development of a membrane filtration 








Figure 2-4: Membrane processes for separating desired dairy components (Brans et al., 2004) 
 
The size difference between the components to be separated by membrane processes should 
be at least a factor of 10. Single whey protein fractionation by conventional membrane 
filtration (UF particularly) is impossible because whey protein components are of similar 
size. In the dairy industry, membrane processes have been used in combination with other 
separation processes for isolation of proteins, however high costs and complicated 
operational procedures pose a challenge to its application (Chik and Saufi, 2010). 
2.4.3 Chromatography 
The term ―chromatography‖ refers to a wide variety of separation techniques, based on the 
partitioning of a sample between a moving phase and a stationary phase. The stationary phase 
is usually packed into a column and a mobile phase ―buffer‖, containing a mixture of solutes, 
is pumped into this column. The separation occurs either through differences in the rates of 
solute movement through the column (caused by differences in interactions of species with 
the stationary phase) or through differential binding of species onto the stationary phase and 
subsequent elution. Separation can be modified by changing the packing chemistry or elution 
buffers. This technique has been used widely for decades for isolation, extraction and 
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purification of peptides and proteins from complex mixtures. In general, proteins or peptides 
are separated with the help of chromatography on the basis of their physico-chemical 
properties such as charge, size and hydrophobicity. Chromatography processes can be 
operated in either batch or continuous modes in packed bed columns, expanded (or fluidized) 
bed columns or stirred (suspended) tanks and, more recently, adsorptive membranes.  
2.4.3.1 Modes of Chromatography 
Packed bed chromatography  
Packed bed/column chromatography is described as a technique that consists of a stationary 
phase placed inside a column through which a liquid mobile phase is passed. Column 
chromatography has been widely used in dairy industry to isolate whey proteins from milk 
(Doultani et al., 2004). It is a multi-step process that requires pre-treatment of the feed 
material, usually centrifugation or filtration through a filter membrane of a particular pore 
size (usually 0.22 or 0.45 μm) to avoid clogging/blocking of the column by suspended solids. 
The diameters of chromatography columns are designed to avoid clogging of the column and 
high back pressure problems. Also, large bead media, for example, Sepharose Big Beads (SP 
BB) (GE Healthcare, Sweden) have been advantageous to reduce clogging problems because 
larger beads have larger intraparticle void spaces within the packed beds, allowing passage of 
some suspended solids. This would also be advantageous for milk and whey processing. Milk 
is complex in nature and the presence of milk fat globules and casein micelles as suspended 
solids would otherwise cause clogging of the chromatography column, thereby leading to less 
complexity. Previously, large-scale fractionation of whey proteins from milk and whey has 
been achieved using this media (Etzel et al., 2000, Fee, 2010). 
Fluidized bed chromatography  
An alternative method used previously for isolation of proteins from crude mixtures has been 
fluidized or expanded bed adsorption (EBA) (Hjorth, 1997). This has been thoroughly 
investigated and has been confirmed to isolate proteins in a single step, without requiring pre-
column filtration to remove suspended solids. Using EBA, Hansson et al. (1994) recovered 
fusion proteins from a fermentation broth without the need of any pre-treatment. The 
adsorption method has also been used for large-scale isolation processes and Shiozawa et al. 
(2001) successfully isolated LF from skim milk using EBA and obtained high product yields.  
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Conrado et al. (2005) used EBA involving a hydrophobic resin to investigate the 
concentration of α-lac in cow milk whey. EBA has also been used in minor protein extraction 
in dairy industries has increased over time. The key attribute of EBA is that bed expansion 
provides large inter-particle spaces that allow suspended particles to pass through the bed. 
EBA thus reduces some of the limitations associated with conventional (packed bed) 
chromatography processes, such as column clogging and high-pressure drops (Billakanti, 
2009). 
Stirred tank chromatography  
Stirred tank/batch adsorption chromatography has offered a few advantages over 
conventional packed bed chromatography and is relatively new to the dairy industry. This 
type of chromatography has been used for on-farm fractionation of whey proteins from milk 
due to the variable fat content in individual cow‘s milk (Chand, 2006). Batch adsorption has 
also been involved in isolating minor milk proteins such as LP, LF and Igs from milk (Foley 
and Bates, 1987). An advantage of this method is that fluids containing suspended solids can 
be processed easily, including whole milk. As whole milk contains suspended particles, 
conventional chromatography has not played a significant role in isolating dairy proteins 
from whole (full-fat) milk. 
This method also includes a few limitations, such as, it involves long processing time. An 
increase in filtration time is expected to be caused by stirring because this can cause 
breakdown of the resin and the fines that develop in turn lead to an increase in process time 
because of clogging of resin capture filters (Chand, 2006). Also, large tanks are necessary for 
this method because the tank must hold large volumes of the feed material and resin (Chand, 
2006). Hence, this method is not preferred in the dairy industry to isolate milk proteins. 
2.4.3.2 Classification of chromatography on the basis of adsorbent chemistry 
Based on the different chromatography resins used, chromatography can be classified into 
different types. The most commonly used resins in the dairy industries include ion exchange 
and affinity resins.  
Ion exchange chromatography  
Ion exchange chromatography is the most widely used separation method, wherein proteins 
are separated based on their charge. This process depends mainly on the pH and salt 
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concentrations of buffer solutions. Elution of bound proteins occurs by varying the buffer pH 
or salt strength (conductivity). For example: an anion exchange adsorption surface with 
diethylaminoethyl (DEAE) moieties will facilitate binding of negatively charged proteins 
because DEAE is positively charged.   
The higher the concentration of charged salt molecules in the solution, the greater is the 
competition for binding to the ligands of the matrix, thus the tendency for protein to 
dissociate from the ion-exchange resin. The protein solution is applied to the column in a 
solution of low salt concentration. The counterions with which the column has been charged 
are not permanently bound but are held by electrostatic interaction (Scopes, 2013). According 
to the charge on the ion-exchange ligands, the ion exchange matrices are divided into two 
types (Selkirk, 2004):  
a. Cation exchange chromatography – The resins are negatively charged and in turn bind 
to positively charged proteins/particles. At a pH below their isoelectric point, the 
proteins are positively charged. Cation exchange is used at a pH below the isoelectric 
point of the protein to be bound.  
b. Anion exchange chromatography – The resins are positively charged and facilitate 
binding of negatively charged proteins/particles. At a pH above their isoelectric point, 
the proteins are negatively charged. It is used at a pH above the protein‘s isoelectric 
point. 
Based on the protein of interest, anion/cation exchange matrices are used and this has been 
the most commonly used separation technique in dairy industries. 
Size exclusion chromatography  
In this type of chromatography, the protein or peptide is dissolved in an appropriate solvent 
and is injected into a column packed with particles of defined pore size because size 
exclusion chromatography separates molecules based on the size. This chromatography is 
also known as gel permeation or gel filtration chromatography. As the molecular size of the 
protein/peptide decrease with respect to the average pore size of the packing, molecules 
penetrate into the pores and as a result elute at a later time. High-molecular-weight material 
elutes first from an SEC column, followed by low-molecular-weight components (Mori and 
Barth, 2013).  
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Whey proteins have been previously isolated from whey filtrate by size exclusion 
chromatography (Bayram et al., 2008). This type of chromatography plays a role in 
separating milk proteins which differ widely in their size but poses a limitation because it 
cannot be used to separate milk proteins that are similar in size. Another disadvantage is the 
limiting capacity for high-volume industries such as the dairy industry because this is a very 
slow process. Hence, it has limited use in dairy industry. 
Reversed-phase chromatography 
Reversed-phase chromatography (RPC) is an important analytical technique that uses a 
hydrophobic ligand as a stationary phase, and has been used for analysis and purification of 
wide variety of substances (Vailaya, 2005). This chromatography has been the most widely 
used method for whey protein quantification. A major limitation of this process is its 
application in dairy industry for separation of whole or skim (low-fat) milk because the 
casein and whey protein elution peaks overlap (Billakanti, 2009). If proteins and peptides 
possess some degree of hydrophobic character, high resolution separation can be achieved by 
reversed phase chromatography but this is mainly of interest analytically because proteins 
must be eluted from RPC columns by harsh solvents that can denature the product. 
Affinity chromatography  
Affinity chromatography is the second most popular type of chromatography used in the 
dairy industry. It separates proteins on the basis of a reversible interaction between a protein 
(or group of proteins) and a specific ligand coupled to a chromatography matrix. This is the 
only known technique that enables the purification of a biomolecule on the basis of its 
individual chemical structure. Also, affinity chromatography is used to isolate pure 
substances present at low concentrations in large volumes of crude sample. In affinity 
chromatography, the immobilised ligand is unique and has very specific binding to its 
counterpart, called an antigen. Some of the affinity interactions include those between 
enzyme and inhibitor, antigen and antibody and hormone and receptor (Janson, 2012). 
Ortin et al. (1991) extracted β-lac from bovine milk using an affinity counter-current 
distribution in an aqueous two-phase system. The efficiency of this method for purifying β-
lac was because of the strong hydrophobic binding ability of this protein. The method was not 
preferred for large scale purification of milk due to its high processing cost and large-scale 
techniques involved. Purification of β-lac from milk was achieved using immunoaffinity 
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chromatography on an antibovine IgG column, followed by anion exchange chromatography 
(Q Sepharose Fast Flow column) to remove residual traces of other whey proteins (Sélo et al., 
1999). Affinity separation of β-lac in its native form with all-trans-retinal immobilized on 
calcium bio-silicate was scaled up and applied to isolate it from industrial whey by Vyas et 
al. (2002). This method also removed α-lac during the isolation process and hence is not 
suitable for purifying milk.     
In general, the most commonly used affinity adsorbents for isolation of Igs from different 
sources are either Protein-A or Protein-G affinity media (Hober et al., 2007, Kochan et al., 
1996). Affinity adsorbents offer a number of advantages over ion exchange adsorbents, 
including high purity of products and selectivity. Although it possesses advantages, a few 
limitations also exist, including the high cost of adsorbents, the need for pre-treated feed 
material and difficult sanitization conditions (Linhult et al., 2005).  
Previously, affinity separation of β-lac was achieved using all-trans-retinal immobilized on 
calcium biosilicate. This process was scaled up and applied to industrial sweet whey solution. 
The research focussed on developing a scale-up process rather than producing a β-lac free 
product (Vyas et al., 2002). Investigation on isolation of β-lac from whey was carried out 
using affinity chromatography without causing any modification to the native structure of this 
protein. This method was applied to whey streams but not to skim and full milk because the 
main aim of this thesis was to use cheese whey for experimental trials (MacLeod, 1995). 
Because of the complex composition of milk, affinity methods have not previously been 
investigated for isolating β-lac from milk. 
2.5 PACKING MATERIAL 
2.5.1 Protein A Mimetic peptide ligand  
Protein A Mimetic ligand appeared to bind β-lac with high specificity while Fee (2010) was 
investigating IgG isolation from bovine milk. Thus, PAM ligand has been first described here 
in relation to its use for affinity binding of Igs.  
A peptide mimicking Protein A for its ability to recognize the fragment crystallizable region 
(Fc region) in Igs was identified through screening of a synthetic multimeric peptide library. 
Compared with Protein A or G, these ligands possess several benefits such as high stability 
towards chemical and biological reagents, absence of contaminants and low production costs. 
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Previously, PAM peptide ligands have been screened, synthesized and investigated for their 
specificity and applications in chromatography process development (Roque et al., 2004, 
Yang et al., 2005). 
Isolation of various classes of Igs from bacterial cell culture broths and human serum were 
successfully investigated using PAM peptide ligand, known as TG19318 tetramer peptide 
ligand (Fassina et al., 1996). Another PAM peptide ligand, known as PAM hexamer peptide 
was identified and characterized for selectivity towards Igs of different classes (Yang et al., 
2005). Also, PAM has previously been shown to be an excellent lead compound for 
downstreaming processing of antibodies in small-scale applications (Dinon et al., 2011). 
PAM has previously been immobilised on a variety of matrices, including Sepharose, 
Eupergit C30N, HyperDW, EmphazeW and Protein-Pak (Fassina et al., 1996). However, to 
date, the applicability of these peptide ligands for isolation of β-lac from dairy streams has 
not been reported. 
PAM is a synthetic peptide which mimics Protein A and has been previously used for the 
recognition of Igs (Billakanti and Fee, 2009). This peptide was purchased from Genscript 
(New Jersey, U.S.A) and has a molecular weight of 2141 a.m.u. The main objective of the 
current research was therefore to investigate the specificity of the tetramer peptide ligand 
towards bovine β-lac. 
PAM peptide ligands are attractive materials because these ligands not only serve as 
alternative affinity media but are also robust and have low production costs. In single-step 
process methods, these ligands have been used as an affinity media to isolate Igs from various 















Figure 2- 5: Schematic representation of tetramer peptide (PAM) 
 
2.6 KINETIC MODELS-PROTEIN ADSORPTION 
In this study, two different kinetic models-Langmuir and Freundlich were briefly studied. 
Previously, these models have been used for reversible adsorption. These are described in 
sections 2.6.1 and 2.6.2. 
2.6.1 Langmuir model 
The Langmuir model, derived by Langmuir in 1916, is one of the simplest adsorption models 
used to describe the kinetics of protein adsorption (Brusatori and Van Tassel, 1999). The 
ability to characterize adsorption equilibria accurately is vital in chemical processes and 
several two- or three-parameter isotherms are used for this purpose .(LeVan and Vermeulen, 
1981). The kinetic equation for the Langmuir model can be written in terms of surface 
concentration ρ, as: 
                                                            
  
  
     (       )                                                    ( ) 
where,      is the surface concentration of protein,    is the amount of protein adsorbed onto 
the surface at time t, Co is the protein concentration in the bulk liquid phase , t is the time, and 
ka and kd are adsorption and desorption rate constants, respectively. As time approaches 



























1-Glycine; 2-Lysine; 3-Lysine; 4-Tyrosine; 5-Threonine and 6-Arginine
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an equilibrium amount of protein adsorbed ρe. This equilibrium value depends on the specific 
bulk protein solution concentration of the experiment and can be calculated from the 
following expression obtained by rearranging in Equation (1). 
                                                                 
  
     
                                                                 ( ) 
In this study, three linearization plots - Scatchard plot, Eadie-Hofstee plot and Lineweaver-
Burk plot were studied. These plots are briefly described in the following sections. 
2.6.1.1 Scatchard plot 
The Scatchard equation is used to calculate the affinity constant of a ligand in contact with 
the protein (3). This plot is a ratio of concentrations of bound ligand to unbound ligand 
against the bound ligand concentration (Debye, 1942). 
                                                                      
 
 
 –                                                          (3) 
In the above equation, Q is the adsorption capacity at equilibrium concentration C, Qo and K 
are constants determined by adsorption experiment. In the experiments performed, solute 
concentration is expressed as mg/mL and adsorption capacities are expressed in mg of β-lac 
per g of tetramer peptide resin. 
2.6.1.2 Eadie-Hofstee plot 
The Eadie-Hofstee plot was developed by Eadie and Hofstee and is one of the graphical 
procedures for determining values of the kinetic parameters for an enzyme-catalyzed reaction 
that conforms to Michaelis-Menten kinetics. The Eadie-Hofstee equation (3) is used to 
determine Qo and K. 
                                                                  
 
 
                                                    (4) 
This plot has been derived from Michaelis-Menten equation describing the dependence 
of enzyme-catalyzed velocity on the concentration of the substrate. As larger amounts of 
substrates are added to a reaction, the available binding sites are filled and hence get 
saturated, ceasing the reaction rate to increase. This concept has been observed in case 
of binding reactions as well, where the binding sites of the resin get occupied with the 
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amount of molecules available in solution, thereby saturating the sites.  
2.6.1.3 Lineweaver-Burk plot 
Lineweaver–Burk plot is a graphical representation of enzyme kinetics which was developed 
by Hans Lineweaver and Dean Burk in 1934. Equation (5) has been previously used to 
determine important parameters in enzyme kinetics such as the Michaelis–Menten constant 
(Km) and maximum reaction velocity (Vmax) (Lineweaver and Burk, 1934). 
                                                                            
   
(    )
                                                            (5) 
Equation (5) is derived from (4) and is used in turn to obtain Langmuir constants. 
(6) 
 
2.6.2 Freundlich model 
The Freundlich adsorption kinetics is mathematically expressed as:  
   
  
     
      
                                                    ( ) 
At attainment of equilibrium, Equation (7) reduces to: 
                                                                     
 
  
                                                               (8) 
where, α1 and α2 are the adsorption and desorption reactions, respectively.  
The Freundlich isotherm is applicable only within certain concentration limits because, given 
an exponential distribution of binding sites, the number of sites increases indefinitely with a 
decreasing association constant, implying that there are an infinite number of sites (Umpleby 


















The demand for dairy bioactive components has seen to rise over the past few years, focusing 
the application of whey proteins in food, healthcare and pharmaceutical industries. To 
achieve this, there is a need to develop economical and improved methods to reduce 
production costs and increase product yield. Due to inherent limitations, the processes 
available at present are not suitable for industrial-scale applications. 
Presence of β-lac was identified as an allergen in bovine milk and the isolation of this protein 
was the main aim of this thesis. This protein is absent in human milk but its presence in 
bovine milk limits its use for infant intake. Previous research has involved the isolation of 
this protein from whey streams. Because of the complex composition of milk, identifying a 
particular ligand showing specificity towards β-lac is a challenge. Another challenge faced 
more recently is the application of this ligand for large-scale purposes.  
The lack of suitable extraction technologies for isolation of β-lac from milk has been a major 
limitation in the production of human-like infant formulae. Previously, the use of PAM 
ligand was observed to isolate Igs from milk and unexpectedly seems to have a high 
specificity towards β-lac; therefore characterization of this ligand was necessary. This ligand 
has also been used to isolate various classes of Igs from cell culture broth and good yield was 
obtained. Thus, optimization of the process will also help in isolating β-lac from milk without 











CHAPTER 3 - MATERIALS AND METHODOLOGY 
This chapter outlines the materials used in this study followed by stepwise protocol of the 
experiments performed. 
3.1 IMMOBILISATION OF TETRAMER PEPTIDE ON A CHROMATOGRAPHY 
MATRIX  
3.1.1 Preparation of solutions 
All chemicals used in this study were purchased from Sigma Aldrich (St. Louis, MO, U.S.A). 
The buffer solutions were prepared using ultra-high pure Milli Q water. To produce Milli Q, 
a unit purchased from Merck Millipore (Billerica, MA) was used. Once the solutions were 
prepared, these were filtered using a 0.22 μm filter (500 mL disposable sterile units, Global 
Science and Technology, Auckland, NZ). Filtration was carried out to avoid clogging of the 
column while performing the chromatography process. The solutions were then sonicated for 
10 min to degas the solutions to avoid air bubbles entering the chromatography column.  
3.1.1.1 Buffer solutions 
a. 10 mM Tris HCl (pH 6.85) – This was prepared by adding 0.6057 g Tris HCl (MW -  
121.14 g/mol) to 450 mL Milli Q water. The pH was then adjusted to 6.85 by dropwise 
addition of 5 M hydrochloric acid and this was made up to 500 mL by adding Milli Q 
water.  
b. 10 mM Tris HCl + 1 M NaCl (pH 6.85) – The buffer was prepared as mentioned in (a) and 
29.22 g sodium chloride was added. The pH of the buffer was then adjusted to 6.85 by 
addition of 1 M sodium hydroxide. 
c. Immobilisation buffer/ coupling buffer (pH 8.5) – Coupling buffer was prepared by adding 
100 mM sodium bicarbonate (NaHCO3; MW - 84.007 g/mol) and 500 mM NaCl to 800 
mL Milli Q water. The pH was then adjusted by dropwise addition of 1 M NaOH. Finally, 
the buffer prepared was made up to 1 L by addition of Milli Q water. 
d. 10 mM sodium phosphate buffer/ binding buffer (pH 7) – 1 L of 10 mM monosodium 
phosphate (NaH2PO4; MW 119.98 g/mol) and 10 mM disodium hydrogen phosphate 
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(Na2HPO4; MW 141.96 g/mol) were prepared separately. The two solutions were then 
combined to obtain a pH of 7.  
e. 10 mM sodium phosphate buffer containing 1 M sodium chloride (pH 7) – 500 mL of 10 
mM sodium phosphate buffer was prepared and 29.22 g/mol NaCl was added to this. The 
buffer pH was then adjusted to 7 by dropwise addition of NaOH. 
3.1.1.2 Coupling solutions 
a. 1 M Tris HCl/ blocking solution (pH 8.5) – 1 M Tris HCl was prepared by addition of 
12.114 g to 100 mL Milli Q water. pH was adjusted to 8.5 by dropwise addition of 5 M 
HCl. 
b. 1 mM hydrochloric acid – 17 µL concentrated HCl was added to 150 mL Milli Q water. 
The solution was then made to 200 mL by addition of Milli Q water.   
c. 1 M sodium chloride – 11.6 g of NaCl (MW – 58.44 g/mol) was dissolved in 200 mL of 
Milli Q water.  
To retain maximum binding capacity of the pre-activated medium prior to the coupling step, 
solutions were kept in an ice box (0 to 4°C). 
3.1.1.3 NHS activated resin 
NHS resin (25 mL pack size) was purchased from GE Healthcare Life Sciences, Connecticut, 
USA. Because NHS resin is supplied in 100% isopropanol suspension (IPA), instructions for 
removal of isopropanol from the medium and preparation for coupling the ligand prior to use 
are given in Section 3.1.2. 
3.1.1.4 Protein A Mimetic peptide 
PAM peptide was purchased from Genscript (New Jersey, U.S.A). The peptide was dissolved 
in the coupling buffer prior to performing the immobilisation process. 
3.1.2 Immobilisation process - protocol  
All necessary solutions were prepared prior to coupling the ligand (Section 3.1.1). The steps 
for coupling include: 
 The ligand to be coupled PAM was dissolved in the coupling buffer at a concentration of 
10 mg/mL. The ratio of volumes chosen was coupling solution/medium – 1:0.5. NHS-ester 
groups rapidly hydrolyzed at high pH. 
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 5 mL of NHS-activated sepharose resin was washed thoroughly with three medium 
volumes of Milli Q water. 
 Washes of the resin were then performed with three medium volumes of cold 1 mM HCl 
in order to remove any IPA present. 
 The resin was again washed with two medium volumes of Milli Q water following which 
washes were performed with three medium volumes of coupling buffer. 
 To the resulting resin, 2.5 mL of 10 mg/mL of PAM peptide was added and left on the 
spinning wheel for 24 hr.  
 Once coupling was done, non-reacted groups were blocked with the addition of 2 mL of 
blocking solution (pH 8.5). This was left on the spinning wheel for three hours. 
 After coupling, the medium was washed with 1 M NaCl. This was repeated thrice and the 
resulting supernatant was discarded. 
 The coupled medium was stored in 20% ethanol until it was ready to be used. 
Once immobilisation was complete, trials were performed to determine the equilibrium 
capacity of the tetramer peptide resin (Section 3.2). 
3.2 AMINO ACID SEQUENCE COMPARISON 
Previously, Protein A Mimetic (PAM) peptide has shown specificity towards IgG since the 
peptide ligand was observed to bind to the FC portion of IgG. A study was carried out using 
SIM – Alignment Tool for protein sequences, to compare the similarities between the FC 
portion of IgG and Bovine β-lac.  
3.3 EQUILIBRIUM/STATIC BINDING CAPACITY DETERMINATION OF 
RESIN 
Initially, protein standards were prepared as described in the following Section (Section 
3.2.1). 
3.3.1 Protein standards 
The whey proteins used in this research (α-lactalbumin, β-lactoglobulin and BSA) were 
purchased from Sigma Aldrich. Varying concentrations of protein solutions were prepared to 
obtain a calibration curve. Protein solutions were prepared by dissolving known amounts of 
proteins in the binding buffer.   
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3.3.2 Nanodrop 1000 UV Spectrophotometer  
Nanodrop 1000 UV Spectrophotometer was used to measure the concentration of samples 
without the need of dilution. 
 Before loading the sample onto the nanodrop spectrophotometer (Thermo Fisher 
Scientific, Wilmington, Delaware, U.S.A), the samples were centrifuged at 12,000 rpm at 
4°C for 1 min. 
  2 μl of the supernatant was pipetted onto the end of a fiber optic cable (the receiving 
fiber). 
 A second fiber optic cable (the source fiber) was then brought into contact with the liquid 
sample causing the liquid to bridge the gap between the fiber optic ends.  
 The gap was controlled to 0.2 mm paths.  
 A pulsed xenon flash lamp provided the light source and a spectrometer utilizing a linear 
CCD array was used to analyze the light after passing through the sample.  
The instrument was controlled by PC based software, and the data was logged in an archive 
file on the PC. 
3.3.3 Langmuir isotherm 
To determine the maximum adsorption capacity of the resin (Q) in contact with a pure β-lac 
protein solution, an adsorption isotherm is necessary.  This was achieved by performing batch 
adsorption experiments involving trials using different concentrations of pure β-lac protein 
solution and the adsorption capacity was then compared at varying time intervals. 
Equilibrium adsorption/desorption of tetramer peptide resin was determined using the 
Langmuir isotherm (Equation 1).  
                                                               
    
(   )
                                                         (9) 
where Q is the adsorption capacity at a given equilibrium solution concentration C, and Qo 
and K are constants determined by the adsorption experiment, with Qo representing the 
maximum binding capacity. Solute concentration is expressed in mg/mL and adsorption 
capacities are expressed in mg of β-lactoglobulin per g of tetramer peptide resin.  
The constants in this equation were calculated from a linearization plot (the Scatchard plot, 
Equation 2) involving the adsorption capacities of the resin at varying concentrations of pure 
β-lac protein solution.  
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From Equation 2, the Langmuir constants were obtained and were hence used to plot a 
Langmuir isotherm. 
3.3.3.1 Preparation of resin 
To determine the isotherms, resin was used in two forms – wet and dry basis. To obtain fully 
dried resin, two washes on filter paper were repeatedly performed using 10 mM sodium 
phosphate buffer (pH 7) at RT and the filtrate was discarded. The remaining resin was left to 
dry at 26.4°C for 48 h. The weight of the dried resin was checked at regular time intervals to 
ensure that it was free of moisture. Once the weight remained constant, the weight of resin 
was obtained for use in dry-basis experiments. 
To obtain wet resin, the weight of the resin was measured after discarding the filtrate. This 
hence gave the weight of resin in wet-basis terms (drained wet resin). 
3.3.3.2 Relation between dry resin and wet resin 
Dry resin was used to perform experiments using batch 1 peptide (purity~99%) whereas 
batch 2 peptide (purity~98%) was used to perform experiments with drained wet resin.  
To obtain a relationship between dry resin and wet resin quantities, dry resin was initially 
weighed and repeated washes (3 times) were alternatively performed with 1 mL each of 
methanol and water at RT. While performing washes, the resin in water/methanol was 
sonicated for 5 min to ensure all the pores of the resin were thoroughly wetted.  The weight 
of drained wet resin was then checked and a linear plot was drawn to obtain a relation 
between dry and wet resin. 
3.3.3.3 Comparison of adsorption capacities at varying time intervals 
Initial experiments were carried out in 5 mL pre-weighed Eppendorf tubes using dry/wet 
resin to which varying concentrations of pure β-lactoglobulin were added. This was left to 
react on the spinning wheel (4
o
C) and was then centrifuged at 10,000 rpm for 1 minute at 
4
o
C. The concentration of the protein remaining in the supernatant was then determined using 
the Nanodrop spectrophotometer. This was repeated at varying time intervals – 10 min, 1, 2, 
3, 4 and 24 h and duplicate measurements of the concentration were noted.  
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Once Q was determined, the slurry was packed into a 5 mL Pharmacia column/empty column 
(GE Healthcare Life Sciences) and trials were performed with regard to isolating β-lac from 
whey/milk samples. 
3.4 ISOLATION OF Β-LAC FROM WHEY/MILK SAMPLES – DYNAMIC 
CONDITIONS 
3.4.1 Preparation of whey solution 
Anchor trim milk was purchased from a local supermarket. In order to remove caseins, milk 
was brought to room temperature (RT) and 5 M HCl was added dropwise with thorough 
mixing until the pH dropped to 4.6. This was centrifuged using an Eppendorf 5810R 
refrigerated benchtop centrifuge at 125 x g at 4°C for 1 minute. The clear supernatant was 
then withdrawn for further use using a pipette and 1 M NaOH was added dropwise to adjust 
the pH to 7.  
3.4.2 AKTA Explorer 10 
Protein purification experiments were performed using an AKTA Explorer 10 system (GE 
Healthcare Life Sciences, Uppsala, Sweden). The purification system was fully automated 
and controlled by Unicorn software 4.0. 
The main system components include an injection valve, sample selection valve, column 
selection valve, system pumps, outlet valve, pH and wavelength detector, flow restrictor, 
autosampler and fraction collector (Frac-950). The autosampler was used to increase 
throughput because it enabled overnight runs (Figure 3-1). The Frac-950 was used to collect 
samples during the purification process. Based on different stages of purification, varying 
fraction sizes were collected. A 10 mL Superloop (a sample holder that holds a large volume 
of sample for repeated injections) was used for larger sample volume injections.  
The system possessed monitors as described below: 
 Monitor pH/C-900 – Monitor pH/C-900 recorded pH, conductivity and temperature 
readings. It also consisted of a control unit, an optional flow cell for conductivity 
and temperature, an optional flow cell with a holder for the pH electrode and the pH 
electrode. The pH cell was not used during chromatography runs 
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 Monitor UV-900 – This can record three wavelengths simultaneously and was used 







Figure 3-1: AKTA Explorer 10 system 
 
Chromatography experiments were conducted for isolation of whey proteins (particularly β-
lac). Varying flow rates were used for varying columns as mentioned in Section 3.3.4. The 
buffer flow rate was controlled by a positive-displacement pump and was normally kept 
constant while the strength of the buffer varied. 
3.4.3 Chromatography column preparation  
 The coupled media was thoroughly washed with binding buffer to remove the storage 
solution (20% ethanol).  
 A 5 mL Pharmacia column was dismantled and immersed in a beaker full of water. This 
was sonicated for 10 min. Alternating with water, 70% isopropanol (IPA) was used and 
sonication was again performed (3X with each solution individually). It was ensured that 









 The bottom end of the column was closed with an adapter which allowed dropwise flow of 
any liquid passing through the column. 
 Binding buffer was poured through the top of the column, using a 2 mL Pasteur pipette. 
 The slurry was mixed well using a Pasteur pipette and was slowly poured into the column, 
letting the buffer pass out through the outlet. 
 It was ensured that there was no air bubble trapped in the column. 
 Once the entire slurry was poured into the column, the slurry was pushed slowly using a 
packing adapter to help settle all packing uniformly. 
 The packing adapter was then carefully removed and a normal adapter was replaced to 
seal the column. 
The column was connected to the lines of AKTA Explorer 10 for use. 
3.4.4 Peptide affinity chromatography 
 Initially, pump washes were carried out using water. 
 Lines A and B were placed in respective buffers and the buffers were flushed through the 
lines to ensure that lines were free of the storage solution (20% ethanol). 
 The column was then equilibrated with the immobilisation buffer/binding buffer, 
depending on the experiments being performed. 
 The column was then equilibrated with the start buffer: 
- Superdex peptide column – 1.5 column volumes (CV) at 0.75 mL/min, backpressure 
limit – 1.8 MPa 
- 5 mL packed column – 5 CV at 1 mL/min,  backpressure limit – 0.3 MPa 
 Using different samples loops, varying concentrations of protein samples and whey 
solutions were separately injected and an existing program was used to control the protein 
purification conditions. 
 Flowthrough fractions and elution fractions were collected in a 96-well microtitre plate. 
 For further analysis, these samples were run on a gel electrophoresis set up for comparison 
with a ladder (MW size marker).   
  The columns were stored in 20% ethanol for long-term use.  
3.5 FREEZE DRYER 
A Labconco freeze dryer/lyophilizer (Total Lab Systems, Auckland, NZ) was used to freeze 
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dry products under a high vacuum. The temperature and pressure were maintained at -47°C 
and 0.070 mBar respectively. With lower injection of whey solution/milk into the AKTA 10 
Explorer system, the absorbance was observed to be low. The resultant isolated proteins 
needed identification and this was achieved by passing them through gel electrophoresis. To 
observe visible bands on the gel, the samples needed to be concentrated and this was 


















CHAPTER 4 - RESULTS AND DISCUSSION 
Initial trials were performed to confirm the immobilisation of the peptide on the resin 
(Section 4.1). To perform these trials, varying ratios of peptide solution to resin volume were 
used as described in Sections 4.1.1 and 4.1.2. Once the immobilisation process was 
confirmed, a relationship between dry resin and wet resin quantities was obtained (Section 
4.2). This relationship was used for further experiments to convert dry resin quantities to wet 
resin quantities or vice-versa. Section 4.3 contains a set of batch experiments that were 
performed to determine the equilibrium binding capacity of the tetramer peptide resin. 
Following this, experimental trials were carried involving chromatographic separation of β-
lac from whey and milk samples. 
4.1 PEPTIDE IMMOBILISATION ON A CHROMATOGRAPHY MATRIX 
Initially, to obtain tetramer ligand-resin immobilisation, coupling was performed as described 
in Section 3.2.2.  Two different ratios of ligand-resin were chosen to obtain immobilisation 
(Sections 4.1.1 and 4.1.2). 
4.1.1 Ratio of peptide solution (concentration-10 mg/mL): resin 
volume~0.5: 1 mL 
The first method used for coupling involved a ratio of peptide:resin (P:R) of 0.5:1 mL. Once 
coupling was complete, samples collected every hour were passed through a Superdex HR 
Peptide 10/30 column. In Figure 4, the chromatogram depicts the absorbances at wavelengths 
280 and 215 nm. The start material was purely PAM peptide solution (10 mg/mL), without 
contact with NHS-activated Sepharose 4 Fast Flow resin. On comparison, the wavelength at 
215 nm showed a higher absorbance value. This is because the absorbance at 280 nm is 
dependent upon the presence of aromatic amino acids in a peptide sequence, whereas 
absorbance at 215 nm is caused by the presence of peptide bonds. As shown in Figure 2-6, 
PAM peptide contains only one aromatic amino acid (tyrosine) which explains why 
absorbance at 215 nm was higher than 280 nm for the start material. 
To further investigate the immobilisation process, the peptide-resin slurry was left to mix by 
inversion on a slowly rotating wheel (RT) to react and the process was monitored every hour. 
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It was observed that the sample isolated after 1 hour of reaction showed greater absorbance at 
280 nm than that at 215 nm. This showed that the solution at the end of the immobilisation 
process contained the by-product of the reaction (succinic-acid) because succinic-acid is 
known to possess a higher absorbance at 280 nm than at 215 nm.  
Using a Superdex HR 10/30 peptide column, elution of peptides, proteins and other 
biomolecules ranging between 100-7000 g/mol is usually observed at around 17-25 mL at a 
flow rate of 0.75 mL/min (GE Healthcare Life Sciences, 2014). Figure 4-1 represents a 
chromatogram showing the absorbance (mAU) of samples obtained from the immobilisation 
solution over time.  It can be observed that the product eluted as a result of the 
chromatographic process was not PAM peptide but succinic acid (MW-118.9 g/mol), which 
was the by-product of NHS/PAM immobilisation reaction. .As expected, the chromatogram 
confirms the presence of succinic acid in the eluted product because it has a higher 
absorbance at 280 nm. Apparently, the 280 nm peaks for 1 and 3 h data overlap which clearly 
shows that there was no further absorbance after the first hour of the reaction. Similar 
overlapping of peaks was observed for 215 nm wavelength. This suggested that 1 h was 




Figure 4-2: Chromatogram showing the absorbance of samples taken from the supernatant of 























Elution volume (mL) 
280 nm - Start
215 nm - Start
280 nm - 1 hr
215 nm - 1 hr
280 nm -  3 hr
215 nm - 3 hr
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4.1.2 Ratio of peptide solution (concentration-10 mg/mL): resin 
volume~1:0.5 mL 
The second method followed to achieve coupling involved the use of a P:R ratio of 1:0.5 mL, 
to check if an increase in the amount of peptide caused an increase in binding capacity of the 
resin. 
Table 4-1 shows a comparison with regard to the area of the individual peaks (mAU•mL) at 
280 and 215 nm wavelengths. There is no clear separation of peaks observed which states 
that there is a mix of PAM peptide and succinic acid (by-product) present. An increase in 
area of the individual peaks at 280 nm was observed on comparing it with the starting sample 
which can be justified due to the mixture of products present. The ratio used for the 
immobilisation process confirmed the saturation of the resin, thereby confirming the absence 
of binding sites remaining for uptake of more β-lac from the solution. 
 
Table 4-1: Area of the individual peaks (mAU•mL) at 280 and 215 nm wavelengths 
comparing immobilisation occurring over varying time intervals (Start, 1 and 3 h) to depict 
the uptake of β-lac by the tetramer peptide resin 
 
Sample Wavelength (nm) Area under the peak (mAU•mL) 
 
Start 
280  1164.33 
215  3448.70 
 
1 h 
280  1976.65 
215  364.24 
 
3 h 
280  1445.54 
215  293.27 
 
Figure 4-2 clearly shows that the eluted sample had an absorbance at 215 nm. The successful 
saturation of the resin was confirmed by comparing the elution volume (mL) to that of the 
start material. This confirmed the presence of residual peptide in the supernatant. A 
conclusion was hence drawn that the entire peptide was not immobilized to the resin even 
after a prolonged time. This is likely to have been because there were no more binding sites 








Figure 4- 3: Chromatogram showing the absorbance of samples taken from the supernatant 
of the immobilisation solution over time, showing the immobilisation process, (P:R–1:0.5 
mL) 
 
4.2 RELATION BETWEEN DRY AND WET RESIN 
Following the steps as mentioned in Section 3.2.3.1, dry resin and wet resin were separately 
prepared. A few experimental trials were performed to obtain a relation between dry resin 
and wet resin quantities. Initial experiments involved the use of dry resin followed by use of 
drained wet resin for subsequent experiments. This alternative method of resin usage was 
suggested to check and confirm if there was any variation in the equilibrium binding capacity 
of the resin (Q). Wet resin was preferred for the remaining experiments because this has been 
the most commonly used form to determine Q (Burton et al., 1999, Fee, 2010). With dry 
resin, it is almost impossible to achieve acceptable packing of a chromatography column with 
small particles (<50 μm) due to electrostatic interactions, which suggests that wet resin (in 
the form of a slurry) is preferable (Costa and Cabral, 2012).  Another drawback of using dry 
resin is the time required to ensure that it is completely dry before the experiments. In many 























Elution Volume (mL) 
280 nm - Start
215 nm - Start
280 nm - 1 hr
215 nm - 1 hr
280 nm - 3 hr
215 nm - 3 hr
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which makes it difficult to compare the binding capacity of the resins. It was expected that Q 
would remain the same for both dry resin and wet resin quantities, when compared on the 
same basis. The reason to obtain a relationship between dry resin and wet resin was because 
this could be used to help convert dry resin to wet resin or vice-versa, thereby leading to a 
consistent basis for comparing Q values.   
A linear plot was obtained which showed a direct correlation between dry resin and wet resin 
(R
2
 = 1.00) (Figure 4-3).  
                                                                                                                                       (1) 
Equation 1 shows that 3.79 was used as the conversion factor to convert wet resin to dry resin 




Figure 4-4: Relation between dry and wet resin 
 
4.3 BATCH EXPERIMENTS  
4.3.1 Equilibrium/ Static binding capacity of Tetramer Peptide resin 
The objective of the work presented here was to obtain the static binding capacity of NHS-
activated Sepharose 4 Fast Flow resin.  Protein binding capacity (static/equilibrium) is a 
y = 3.79x 
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critical parameter for chromatography media because it determines how much media is 
needed to purify a certain amount of protein (GE Healthcare Life Sciences, 2011). To find the 
maximum adsorption capacity of the tetramer peptide resin in contact with a pure β-lac 
protein solution, an adsorption isotherm was required.  
To determine Q (mg/g), linearization plots were first obtained and the plot which best fit the 
data was chosen to determine the Langmuir constants. Using the two P:R ratios as mentioned 
in Section 4.1, different plots (Section 4.3.1.1 and 4.3.1.2) were obtained to determine Q. For 
the sake of consistency, the pH of sodium phosphate buffer was set to 7 in all tests. All other 
conditions were maintained constant in both the cases to allow a direct comparison between 
different experiments. 
4.3.1.1 Ratio of peptide solution (concentration-10 mg/mL): resin volume~0.5:1 mL 
Wet resin Basis Measurement of Equilibrium Binding Capacity  
Following the first ratio used (Section 4.1.1) and the protocol described in Section 3.2.2, β-
lac was allowed to remain in contact with the tetramer peptide resin for 3 h. Figure 4-4 shows 
the Scatchard plot obtained which was observed to be the best fit for the data points. In Table 
4-2, R
2 
values are observed to vary with every plot used and Scatchard plot was ultimately 
seen to be the best fit, although the Lineweaver-Burk plot was almost as good. This was 





Figure 4- 5: Scatchard plot for wet resin at 0.2, 0.5, 1.65, 4.62, 8.93 and 21.89 mg/mL β-lac, 
after 1 h binding 
 
Table 4-2: Comparison of varying Linearization plots determining the best fit for wet resin 
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2
 value Qo   K  
Scatchard plot 
      
 
 







      
 
 




























The time interval chosen was to allow maximum binding time, which is clearly depicted in 
Figure 4-5  which also shows a clear comparison between the varying time intervals (1, 2 and 
3 h) with respect to the varying binding capacities corresponding to β-lac concentrations.  
y = 43.18x - 2.93 




















Figure 4-5 is a clear illustration in explaining the fact that 1 h was sufficient for allowing all 




Figure 4-6: Adsorption capacities (mg/g wet resin) at 0.7, 1.55, 3.32, 6.88, 12.46 and 26.22 
mg/mL β-lac, after 1, 2 and 3 h binding  
 
Using the Langmuir constants (Qo = 43.18 mg/mL, K = 2.93 mg/mL) as obtained from Figure 
4-4, the Langmuir isotherm was plotted (Figure 4-6), showing a good fit to the data. It was 
observed that increasing β-lac concentrations led to an increasing trend. Examining this 
gradual increase, there was a possibility for the data points to fit either a Langmuir/ 
Freundlich plot. Due to time constraints, Q for higher concentrations of β-lac was not 
determined. Examining further data would help confirm which isotherm would be the best fit 































Figure 4-7: Langmuir isotherm for β-lac adsorption to a resin prepared with peptide 
solution:resin volume~0.5:1 mL, after 1 h binding 
 
Dry resin Basis Measurement of Equilibrium Binding Capacity  
 Experiments involved using tetramer peptide-resin in the form of dry basis were also 
performed. The protocol described in Section 3.1.2 was followed with a minor change of 
using dry resin rather than drained swollen wet resin. In this case, β-lac was allowed to 
remain in contact with the tetramer peptide resin for 4 h to determine Q.   Figure 4-7 shows a 
Scatchard plot which is observed to be the best fit for the data points whereas Table 4-3 
compares the R
2 
values of varying plots. The values hence obtained were used to determine 
the Langmuir constants.   
Table 4-4 illustrates the varying initial concentrations of β-lac that were determined using the 
Nanodrop. A random range of initial concentrations was chosen to determine Q. Considering 
lower concentrations of β-lac (0.58 and 1.22 mg/mL), there was no variation observed in the 
binding capacity of the resin (Table 4-4). This likely was expected due to experimental error 
because a gradual increase in Q with the remaining concentrations of β-lac was noticed and 
this was consistent. In all cases, the dry resin data was converted to wet resin basis quantities 










































Figure 4-8: Scatchard plot for dry resin experiments (converted to wet resin basis) at 0.02, 
0.02, 0.08, 0.41, 1.1, 2.12, 3.2, 3.54, 7.77 and 12.29 mg/mL β-lac after 1 h binding 
 
Table 4-3: Comparison of Linearization plots determining the best fit for dry resin (converted 
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2
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y = 142.41x - 0.72 























Table 4-4: Equilibrium binding capacities at varying β-lac concentrations, after 1 h binding 
 
Initial conc of β-lac 
(mg/mL) 
Conc of residual β-lac after 1 h 
(mg/mL) 
Q (mg/g) 
0.58 0.02 3.59 
1.22 0.02 3.59 
2.43 0.08 14.36 
4.83 0.41 51.16 
9.17 1.10 85.85 
11.70 2.12 106.20 
13.14 3.20 116.16 
13.70 3.54 118.23 
21.04 7.77 130.27 
25.90 12.29 134.49 
 
Figure 4-8 shows the change in Q with time obtained corresponding to varying β-lac 
concentrations. It is clearly observed that the maximum adsorption capacity was obtained 
after the first hour of the reaction. This indicates that the resin was saturated and hence all 
binding sites were occupied, which prevented further binding. A decrease in binding was 
observed at 4 h interval and this seemed to be an outlying data point because it was 





Figure 4-9: Adsorption capacities (mg/g wet resin) at 0.58, 1.22, 2.43, 4.83, 9.17, 11.7, 
13.14, 13.7, 21.04 and 25.9 mg/mL β-lac, after 1, 2, 3 and 4 h binding  
 
The Langmuir constants obtained from Scatchard plot (Table 4-2) were used to plot a 
Langmuir isotherm. Figure 4-9 shows that the tetramer peptide-resin reached its maximum 
equilibrium adsorption capacity of 134.49 mg/g wet resin at a concentration of 12.29 mg/mL 








































Figure 4-10: Langmuir isotherm for β-lac adsorption to a resin prepared with peptide 
solution:resin volume~1:0.5 mL, after 1 h binding dry resin  
 
Comparing Figures 4-6 and 4-9, Q increased approximately three-fold in the latter case. 
Although both the Langmuir isotherms were plotted following the same experimental 
conditions and protocol, the plot shown in Figure 4-9 was for data from a resin that contained 
triple the amount of peptide as that in Figure 4-6. A calibration curve (Appendix) was used 
for this plot and hence the variation observed was triple when compared to Figure 4-6. It is 
obvious that an increase in peptide concentration during immobilisation increased the ligand 
on the resin surface, which in turn led to a higher binding capacity. However, further work is 
needed to quantify and confirm this behavior. 
4.3.1.2 Ratio of peptide solution (10 mg/mL):resin volume~1: 0.5 mL 
Considering the ratio as mentioned in Section 4.1.2, Langmuir constants were determined to 
plot a Langmuir isotherm. From Table 4-3, the Scatchard plot was observed to be the best fit 


































Figure 4-11: Scatchard plot for dry resin (converted to wet resin basis) at 0.18, 1.03, 2.16, 
8.55 and 21.25 mg/mL β-lac, after 1 h binding 
 
Table 4-5: Comparison of Linearization plots determining the best fit for dry resin (converted 
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Similar to Figure 4-6, a plot was drawn to determine the maximum binding capacity of the 
resin. Trials were performed for 2 h duration and equilibrium appeared to to attained after the 
first hour, which is consistent with the above results. This confirmed that 1 h was sufficient to 
complete β-lac binding to the tetramer peptide resin. 
y = 56.31x - 0.86 




















Figure 4-11 shows a time comparison plot of the amounts of β-lac bound to the resin. The 
quantities of β-lac bound to the resin remained essentially constant within experimental error. 
The conclusion drawn from the above results hence remained consistent, proving that 1 h was 




Figure 4-12:  Adsorption capacities (mg/g dry resin) at 1.82, 3.57, 6.78, 13.02 and 26.97 
mg/mL β-lac, after 1 and 2 h binding  
 
The Langmuir constants obtained from Table 4-5 was used to plot a Langmuir isotherm 
(Figure 4-12). Similar to Figure 4-6 the trend seemed to increase at higher concentrations of 
β-lac and there was no stability observed. Time limitations did not allow trials with higher 
concentrations of β-lac to confirm whether Langmuir isotherm or Freundlich isotherm was 

































Figure 4-13: Langmuir isotherm for β-lac adsorption to a resin prepared with peptide 
solution:resin volume~1:0.5 mL, after 1 h binding  
 
From Figure 4-12 it is observed that tetramer peptide resin reached its maximum equilibrium 
adsorption capacity of 54.11 mg/g resin at a concentration of 21.25 mg/mL pure β-lac 
solution. Hence as expected, an increase in peptide concentration confirmed an increase in Q. 
As shown in Figure 4-6 and 4-12, Q is observed to be 39.01 and 54.11 mg/g dry resin 
respectively but Figure 4-9 corresponds to an increased Q of 134.49 mg/g wet resin (wet resin 
and dry resin were interchangeable using the linear relation as shown in Section 4.2). To 
confirm the concept that with an increase in peptide concentration a higher Q is obtained, 
repetitive trials need to be performed which was not achieved in this research because of time 
constraints. 
4.3.2 Langmuir isotherm with varying salt strengths 
Following the determination of Q, experimental runs were performed using varying salt 
strengths to measure the dependence of Langmuir isotherms on salt concentration. Figure 4-
13 shows a gradual decrease in Q with increasing salt concentrations. Duplicates were 
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concentrations of β-lac.  
The data for the curve denoted ―No added NaCl‖ contained only sodium phosphate buffer 
with no added NaCl. The remaining isotherms were obtained in presence of varying salt 
strengths. In the case of ion exchange chromatography, it is always noted that higher salt 
strengths weaken the strength of protein binding (Yamamoto et al., 1988, Kaltenbrunner et 
al., 1993) and therefore one would expect a progressively lower maximum binding with 
increasing salt addition.  
Because initial experiments showed that a high salt concentration (1 M NaCl) effectively 
elutes β-lac from the resin, it was proposed that PAM peptide might behave as an ion 
exchange material. However, the expected drop in Q at higher salt concentrations did not 
occur (Figure 4-13) but rather the Langmuir isotherm increasingly showed a linear form.  
Qualitatively, Langmuir isotherms are known to follow a linear trend where the number of 
adsorption sites greatly exceed the available adsorbent molecules but saturate beyond a given 
concentration due to an increase in occupancy sites (Sattler, 2010). This may be one reason 
for the trend observed in Figure 4-13. However, more work is necessary to draw any firm 








Figure 4-14: Determination of adsorption capacities (mg/g dry resin) in presence of 20, 40, 
80, 160 and 320 mM NaCl  
 
4.3.3 Elution of bound β-lactoglobulin 
After binding of β-lac by the tetramer peptide resin, it must be eluted without causing damage 
to the structure/function of the protein. Trials were performed initially involving 0.1 M citric 
acid and variation in the salt strengths maintaining constant pH and concentration of β-lac 
solutions.  This did not seem to give a high recovery percentage; the use of citric acid and 
varying salt strengths at varying pH was henceforth chosen to check the effectiveness of β-lac 
elution by pH change. 
Citric acid is commonly used to elute Igs off Protein A and other proteins from affinity 
chromatography matrices (Hahn et al., 1998, Boardman and Partridge, 1955). Because the 
ligand was originally designed as a Protein A mimetic, trials were performed involving 0.1 M 
citric acid. For consistency, the pH of citric acid was maintained constant (~6.02).  
Figure 4-14 shows the recovery of bound β-lac. Citric acid eluted β-lac but 100% recovery 
was not observed. The percentage of β-lac eluted at varying salt strengths remained almost 
consistent at 60%. Varying salt strengths and pH change are known to elute the bound protein 





























trial, a conclusion was drawn that there was no change observed in the percentage recovery, 




Figure 4-15: Elution of bound β-lac using 0.1 M citric acid in presence of 20, 40, 80 and 160 
mM NaCl at constant pH (~6.02) 
 
Trials were then performed using 0.1 M citric acid at varying pH. A particular concentration 
of β-lac (26.1 mg/mL – 26.6 mg/mL) was chosen and 0.1 M citric acid (varying pH) was 
added to the pellet to observe if varying the pH value caused any variation in the elution of 
the bound protein. From Figure 4-15 it is clearly observed that pH did not affect the elution of 
bound β-lac. The percentage of β-lac eluted varied between 32% and 35% with varying pH 
values. Hence, pH variation did not affect the elution process. 
Thus the presence of salt in citric acid showed a higher recovery percentage compared with a 
variation of citric acid pH in absence of NaCl.  
A conclusion regarding mode of binding of the ligand could not be drawn because the major 
properties of ion exchangers include elution of bound material involving a variation in the 
ionic strength and pH of elution buffers (Hahn et al., 1998, Williams and Frasca, 2001). The 
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contrary, the result in Figure 4-15 does not support the ion exchange property of the resin 
since a variation in pH of the buffer did not cause any variation in elution and the recovery 
percentage of the bound protein remained consistent. Due to time constraints, further 




Figure 4-16: Elution of bound β-lac using 0.1 M citric acid at varying pH (3.04 – 6.32) 
 
Once conditions were tested with regard to the elution of bound protein, a study was carried 
out to isolate β-lac by feeding whey solution and milk through a chromatography column, 
carefully packed as described in Section 3.3.3. 
4.4 DYNAMIC CONDITIONS – SEPARATION OF Β-LAC 
The main objective of the work presented here was to test the separation of β-lac from  
 Whey solution 
 Milk 
To isolate β-lac, whey solution was initially passed through a 5 mL chromatography column 
(packed with slurry). These trials were performed using the ratios as described in Section 
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4.4.1 Ratio of peptide solution (10 mg/mL):resin volume~0.5: 1 mL 
Initial trials were performed by passing varying volumes of sample through a 
chromatography column packed with the prepared tetramer peptide resin.  
4.4.1.1 Whey solution~varying injection volumes 
Injection –  0.25 mL, 0.5 mL and 4 mL whey samples  
Figure 4-16 (a) shows a clear comparison between varying injection volumes of acidic whey 
(pH 6.8). The result seems consistent when comparing the elution volume of each injection. 
Another factor considered for analysis was the conductivity (mS/cm). β-lactoglobulin was 
observed to elute at the same conductivity (15-15.8 mS/cm) in every trial. As expected, with 
higher injection volume there was a higher absorbance observed. To characterise the 
components of the various peaks in the chromatogram shown in Figure 4-16, gel 




Figure 4-17: Chromatogram for various injection volumes of whey solution (0.25, 0.5, 4 mL 
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The SDS-PAGE gel image shown in Figure 4-17 shows a clear separation of proteins that 
were obtained as an outcome of the chromatographic separation process. This was compared 
with a molecular-weight size marker/ ladder (L) which was used as a standard to help identify 
the approximate size of the protein. The pooled elution fractions were loaded in lane 2, 
corresponding to flowthrough fractions A4-A12.  Figure 4-17 confirms the presence of β-lac 
as a dark band at the expected molecular size (18.6 kDa). Lane 3 (corresponding to Peak 1 in 




Figure 4-18: SDS-PAGE gel image, showing the protein composition of feed, flowthrough 
and elution fractions from chromatogram in Figure 4-16 – for 0.5 mL whey solution 
 
In lane 2, various proteins present in whey solution are shown, which is the starting sample 
(Figure 4-18). Fractions A6 – A16 (lanes 3-6) were flowthrough fractions which consisted of 





   1      2       3     4     5      6       7 
4-23 
 
fractions which include α-lac, β-lac, BSA, and Igs. Lanes 7-18 shows the presence of β-lac and 
minor traces of BSA.  To prevent loss of protein (β-lac) in the flow through fractions, it is 




Figure 4-19 : SDS-PAGE gel image showing the protein composition of feed, flowthrough 
and elution fractions from chromatogram in Figure 4-16 for 4 mL whey solution  
 
 Injection – 10 mL whey sample  
As expected, an increase in β-lac binding with an increased injection volume was observed as a 
result of injecting 10 mL of whey. The chromatogram in Figure 4-17 shows the separation of 
various whey proteins as a result of 10 mL whey injection. Fractions A4–A12, and B12–B7, also 
known as flow through fractions, consists of unbound whey proteins. The bound and unbound 
proteins as a result of the chromatographic process were confirmed by running the samples 














Figure 4- 21: SDS-PAGE gel image, showing the protein composition of flowthrough 





















































A4 – A12, B12 – B7 
 
A3 – A12, B12 – B5 
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Figure 4-20 shows bands of whey proteins that passed through the column without binding. The 
presence of bands throughout the lanes was explained by the number of proteins present in milk. 
Milk used for the experimental trials did not involve any pre-treatment, which meant there was no 




Figure 4-22: SDS-PAGE gel image, showing the protein composition of elution fractions 
from chromatogram 4-19 for 10 mL whey solution 
 
The elution fractions were seen by gel electrophoresis to contain a mix of BSA, β-lac and α-
lac (Figure 4-21). Similar to Figure 4-17, elution fractions possessed a mixture of whey 
proteins. Because only traces of other proteins were present, it was concluded that the 
tetramer peptide resin showed a strong affinity for the protein of interest (β-lac).  
4.4.1.2 Injection – 1 mL pasteurised milk 
To obtain separation of β-lac from milk, the first trial involved an injection of 1 mL 
pasteurised milk. Figure 4-18 clearly shows the separation of a major portion of milk proteins 
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represent the proteins that were eluted at a conductivity of 15.3 mS/cm. The eluted proteins 
were observed to have a low absorbance and had to be concentrated to enable clarity of the 
bands depicting different proteins when loaded onto the gel. These eluted proteins were hence 
lyophilized using a freeze dryer. The concentrated samples were clearly visible on the SDS 
gel electrophoresis (Figure 4-23).The starting sample contained full-concentration milk 
without pre-treatment and the flow through fractions seemed to be highly concentrated due to 
the presence of the remaining milk proteins. To obtain a clear chromatogram it was suggested 
to load a diluted sample of milk with higher injection volume. This would give an initial 
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Figure 4-24: SDS-PAGE gel image showing the protein composition of feed, flowthrough 
and elution fractions from chromatogram as in Figure 4-22 for 1 mL milk  
 
Further experiments were performed based on the varying ratio of tetramer peptide resin 
which is described in the following sections. The experiments were performed to obtain a 
comparison between the two different procedures followed for immobilisation of peptide to 
the resin involving different ratios of peptide and resin. 
4.4.2 Ratio of peptide solution (10 mg/mL):resin volume~1:0.5 mL 
After the above trials were successfully completed, the column was packed with freshly 
prepared tetramer peptide resin mixture and varying samples were injected into the column. 
4.4.2.1 Whey samples~varying volume injection 
On comparing injection volumes of whey solution (1 mL and 4 mL), the elution of the bound 
protein seemed consistent with both the cases. This was in turn proved by running a gel 
electrophoresis (Figure 4-25). A clear separation of bound β-lac was observed and traces of 
BSA were also present in the elution fractions.  
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method gave a better separation of the bound protein. In Figure 4-17, β-lac eluted at a 
conductivity of 15.2 mS/cm with an absorbance of 126.65 mAU. Figure 4-25 showed that the 
bound protein eluted at a conductivity of 15.6 mS/cm and had an absorbance value of 135.65 
mAU.  
Though there was not much difference seen between the varying ratios used as packing 
material, Figure 4-25 was seen to possess a slightly higher absorbance value compared to 
Figure 4-17. With the same injection volume (4 mL whey), the ratio of P:R~1:0.5 mL gave a 
better separation of β-lac, which was supported by Figure 4-12. As expected, with a higher 
binding capacity better separation of β-lac was obtained. 
Figure 4-25 shows a higher absorbance at 280 nm which suggests that the ratio of P:R~1:0.5 
mL is preferred over P:R~0.5:1 mL. Higher binding capacity obtained (mg/g wet resin) 
strongly suggests that better separation of β-lac can be achieved with the immobilisation ratio 
of P:R~1:0.5 mL. Hence, this result supports the fact that with a higher peptide concentration 




Figure 4-25: Chromatogram showing a comparison for 1 mL and 4 mL whey solutions as 
















































Elution volume (mL) 
1 mL whey 4 mL whey Cond
A6 - A16 







Figure 4-26: SDS-PAGE gel image showing the feed, flowthrough and elution fractions of 
chromatogram in Figure 4-24 for 4 mL whey solution  
 
4.5 AMINO ACID SEQUENCE COMPARISON – FC AND β-LAC 
As described in Section 3.2, the SIM-Alignment Tool was used to compare the amino acid 
sequence of FC portion of IgG and β-lac. As shown in Figure 4-26, 100% identity in five 
residues - RTPEV (red), 75% identity in four residues – PTPE and PAPE (yellow) and 75% 
identity in four other residues -  PAVF and PSVF (blue) overlap was observed. It was 
expected that the identified regions showed specificity towards β-lac and was responsible for 
successful binding of β-lac to the tetramer peptide resin.  This needs to be further investigated 
to confirm if the identified regions were the actual sites causing binding of β-lac to the 












MKCLLLALAL TCGAQALIVT QTMKGLDIQK VAGTWYSLAM AASDISLLDA 
QSAPLRVYVE ELKPTPEGDL EILLQKWENG ECAQKKIIAE KTKIPAVFKI 
DALNENKVLV LDTDYKKYLL FCMENSAEPE QSLACQCLVR TPEVDDEALE 
KFDKALKALP MHIRLSFNPT QLEEQCHI   
 
FC portion of IgG: 
TCPPCPAPEL LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK 
FNWYVDGVEV HNAKRKPREE QYNSTYRVVS VLTVLHQDWL NGLEYKCKVS 
NKALPAPIEL TISKAKGQPR EPQVYTLPPS REEMTLNQVS LTCLVKGFYP 
SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS 
CSVMHEALHN HYTQKSLSLS PGK   
     
Figure 4-27: Amino acid sequences of bovine β-lac sequence and the FC region of IgG, 
showing a matching set of amino acids RTPEV (red), PTPE and PAPE (yellow) and PAVF 











CHAPTER 5 - CONCLUSIONS AND RECOMMENDATIONS 
5.1 CONCLUSIONS 
This thesis describes an attempt to characterize an affinity ligand for the isolation of β-lac 
from bovine milk. The overall findings of this study are briefly described below. 
5.1.1 Tetramer peptide resin immobilisation 
PAM was successfully immobilized to NHS-activated Sepharose 4 Fast Flow resin via amine 
coupling. Immobilisation was confirmed by observing a gradual decrease in peptide 
concentration over time when incubating a PAM solution with the activated resin. In 
particular, by the end of immobilisation, there was no absorbance observed at 215 nm, which 
indicated complete uptake of the peptide by the resin. The sample collected after 1 h of 
immobilisation process when passed through the chromatography column, was observed to 
have a higher absorbance at 280 nm than 215 nm. Succinic acid, being the by-product of the 
immobilisation reaction, was observed on completion of the immobilisation process. This 
was confirmed by comparing the absorbance values, of which 280 nm was higher, as 
expected.    
Investigations were carried out involving two different P:R ratios and succinic acid was 
clearly visible in both cases from the chromatograms obtained. As expected, the ratio of P:R 
containing a higher peptide concentration was observed to release a higher amount of 
succinic-acid, thereby indicating the saturation of the reaction sites present on the resin. 
5.1.2 Adsorption/Batch experiments 
On completion of immobilisation, it was necessary to determine the equilibrium/static 
binding capacity of the resin. To achieve this, adsorption/batch experiments were performed, 
as a result of which it was observed that the uptake of β-lac by the tetramer peptide resin 
depended on the concentrations of pure β-lac solution. Varying time intervals were chosen to 
identify the entire uptake of β-lac present in the solution by the tetramer peptide resin. Trials 
were performed to determine the consistency and in all cases 1 h was observed to be 
sufficient after which no further immobilisation occurred. 
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Results confirmed that increasing the peptide concentration during immobilization led to 
more uptake of the protein from the solution during subsequent binding and hence led to a 
higher binding capacity. As expected, the maximum binding capacity, Q, of the slurry 
possessing a higher peptide concentration was observed to be 54.11 mg/g wet resin and the 
slurry containing a lower peptide concentration had a lower binding capacity of 39.01 mg/g 
wet resin.  
Following the determination of Q, an experiment was performed using the concentration of 
PAM peptide, obtained as a result of the calibration curve. The slurry hence prepared 
contained peptide concentration three times higher than the previous trials. As expected, there 
was a three fold increase in Q observed. Hence, increasing the peptide concentration resulted 
in higher Q (134.49 mg/g dry resin). 
5.1.3 Elution Experiments 
Once the binding capacity of the resin was determined, elution of bound β-lac was 
investigated. Varying the salt strength in presence of citric acid and simultaneous variations 
in the pH of the solution were tested in an attempt to obtain a high recovery of the bound 
protein so as to utilize the resultant product in further applications. The recovery of β-lac 
varied between 59%-62% (for varying pH), but with a change in pH, only 35% of bound 
protein was seen to elute. Hence, a change in pH did not cause the entire protein to elute off 
the resin. Because of time constraints, further experiments were not performed to obtain a 
higher recovery of bound β-lac. 
5.1.4 Peptide affinity separation of β-lac from whey solution and milk 
Using tetramer peptide slurry, a 5 mL column was packed and whey/milk samples were 
injected to obtain clear separation of the protein. The results showed a clear separation of β-
lac from whey and milk samples, confirmed using gel electrophoresis (Section 4.4). 
Investigations carried out were consistent with the tetramer peptide resin behaving as an 
affinity matrix rather than an ion exchanger. This could be confirmed by performing 
repetitive runs with varying injection volumes of milk to obtain consistency. The tetramer 
peptide resin was used in this research only at small scale but should be tested for use in 
industrial separation of β-lac from milk. 
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5.1.5 Applications  
The tetramer peptide ligand characterized in this work has potential advantages over 
conventional chromatography methods for selective isolation of β-lac from whey/milk. 
Although this ligand has been used previously for selective isolation of Igs from human 
serum and cell culture broths, the use of this peptide for removal of β-lac from dairy streams 
has not been reported previously.  
The buffers used in the isolation process were very mild (neutral pH and with a conductivity 
of less than 8 mS/cm). Because elution of β-lac can also be achieved using a very mild salt 
strength (15 mS/cm), the purified milk has applications in the manufacture of infant 
formulae. β-lactoglobulin can also be concentrated after separation from milk using a 
lyophilizer and then used as an additive in confectionary and protein supplement industries or 
as a gelling agent or binder for food.  
5.2 RECOMMENDATIONS FOR FUTURE WORK 
In this study, a few conclusions were drawn based on the experiments performed but because 
of time constraints a few experiments must be repeated to improve confidence in the results. 
Some of the recommendations for future work are as follows: 
 Trials were performed by increasing the peptide concentration during ligand 
immobilisation, which gave a higher binding capacity value but repetitive trials are 
needed to confirm this. For example, doubling the peptide concentration could be 
attempted to help compare it with the result obtained. 
 A Langmuir isotherm was used in all cases to fit the data points but checking the 
binding capacity of the resin by trying a few more concentrations of pure β-lac 
would be helpful to compare whether Langmuir or the Freundlich isotherm was the 
best fit. 
 Having identified that the presence of NaCl (in 0.1 M citric acid) gives 60% 
recovery of the bound protein, trials could be performed to increase the recovery 
percentage. Addition of 0.2 M acetic acid as an eluting agent may be worthwhile to 
try, because this has been previously used for recovering IgG and a high recovery 
percentage was attained. 
 Investigation in this research indicated that the PAM peptide behaves as an affinity 
matrix, because it showed affinity towards β-lac in particular, with only minor 
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traces of α-lac present in the eluted product. Increasing the injection volume may 
possibly help eliminate α-lac binding and this should be investigated. 
 The PAM peptide structure is quite complex and would be expensive to produce. 
Therefore, trials with various PAM peptide structural analogues, in particular 
simplified structures, preferably with a linear structure, can also be performed to 
attempt affinity isolation of β-lac from milk. 
 Further investigation needs to be carried out to confirm if the identified region on 
the amino acid sequence of β-lac was the actual cause for binding to occur, due to 
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APPENDIX A: β-LAC UV ABSORBANCE CALIBRATION CURVE 
Initial experiments were performed to obtain the extinction coefficient of β-lac. Trials were 
performed at varying concentrations of pure β-lac solutions. The absorbance at 280 nm was 





Figure A-1: Determination of extinction coefficient of β-lac 
 
A calibration curve was plotted using absorbance at 280 nm for known concentrations of pure 
β-lac solutions (Figure A-2). This calibration curve was used to determine unknown 
concentrations of β-lac in experiments (Section 3.3.1).  
y = 16.83x - 0.16 





















































y = 1.14x 
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APPENDIX B: PAM UV ABSORBANCE CALIBRATION CURVE 
To maintain consistency with varying concentrations of PAM peptide, the calibration curve 
(Figure A-4) was used. Using the calibration curves unknown concentrations of PAM peptide 








Figure B-2 : Calibration curve of PAM to determine unknown concentrations 
y = 8.42x 


























y = 3.37x 
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